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“We are part of this universe; we are in this universe,  
but perhaps more important than both of those facts is that the universe is in us.” 
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Introdução: Compreender a interação entre Plasmodium e o mosquito Anopheles é 
crucial para o desenvolvimento de estratégias de controlo e eliminação da malária em 
áreas endêmicas. A invasão das glândulas salivares do mosquito vetor é uma das etapas 
mais importantes para a transmissão da malária. Compreender como Plasmodium 
interage com esse órgão é fundamental para o controle e eliminação da malária. Muitos 
glicanos estão implicados na interação célula-célula e podem desempenhar um papel 
central na interação do parasita com o hospedeiro. O glicano Galα1-3Galβ1-4GlcNAc-R 
ou simplesmente α-Gal é um antígeno importante para o sistema imunológico humano e 
está presente no Plasmodium. 
Objetivos: Neste trabalho pretendemos compreender o papel da α-Gal durante a invasão 
das glândulas salivares de Anopheles spp. e estabelecer a origem da α-Gal presente no 
Plasmodium. 
Métodos: Para deteção da α-Gal usou-se a técnica de microscopia de imunofluorescência 
em esporozoítos de Plasmodium bergei ANKA-GFP (SPZs), oocineto e oócitos, fixados 
com paraformaldeído a 4% e incubados com o mAbs anti-α-Gal_IgG2b e o secundários 
IgG anti-rato conjugado com Alexa fluor- 647, com mAbs anti-CSP conjugado com 
Alexa fluor-647 ou com a Isolectina BSI-IB4 conjugado com o fluoróforo Alexa fluor-
647. O antígeno α-Gal foi detectado no intestino médio (MGs) e nas glândulas salivares 
(SGs) dos mosquitos por microscopia de imunofluorescência e Western Blots. 
Esporozoítos (SPZs) expressando α-Gal, coletados do MGs (8º aos 23º dias pós-infeção), 
hemolinfa (14º ao 23º dpi) e SGs (14º ao 23º dpi) de An. Stephensi, foram detetados e 
quantificados por citometria de fluxo. A expressão do gene UDP-GalT em SPZs obtidos 
a partir de MGs e SGs, de diferentes dias pós-infeção, foi quantificada por RT-qPCR e 
comparado usando o método 2-ΔΔct. O papel de α-Gal na interação Plasmodium e as 
glândulas salivares foi investigado. Os genes do UDP-GalT e das lecitinas do tipo C 
(CTL) do mosquito foram silenciados usando o método RNA de interferência. RNA(s) 
de fita dupla específico foi injetado em mosquitos com 8º dia após-infeção. O 
silenciamento dos genes foi confirmado por RT-qPCR e no 18º dpi as SGs e as MGs 
foram dissecados e os SPZs quantificados usando o hemocitómetro. O número de SPZs 
foi comparado com os grupos controle injetados com dsRNA não relacionado. A presença 
de α-Gal no ensaio de gliding dos SPZs foi investigado usando mAbs anti-α-Gal 
conjugados com Alexa fluor-647. Além disso, o efeito de mAbs anti-α-Gal e Leciona 
BSI-IB4 no movimento de glinding dos SPZs foi testado usando microscópica. 
Resultados: A presença de α-Gal foi detetada por microscopia de imunofluorescência no 
intestino médio e nas glândulas salivares do mosquito e em esporozoítos e oocinetes de 
Plasmodium. A percentagem de SPZs que expressaram α-Gal em citometria de fluxo em 
diferentes dias pós-infeção, não apresentaram diferença significativa entre esses, mas 
quando SPZs de diferentes origens (SGs, HL e MGs) foram comparados, os SPZs das 
SGs apresentaram expressão significativamente mais elevada de α-Gal. O número de 
SPZs de SGs foi reduzido quando o gene UDP-GalT dos mosquitos foi silenciado, 
enquanto nenhuma diferença foi observada no número de SPZs das MGs, mas uma 
percentagem reduzida de SPZs expressando α-Gal e menor intensidade de α-Gal foi 
observada nas provenientes das MGs, mas não nas SG. Dos três genes alvo da lectina do 
tipo C (CTL)-galactose silenciados com dsRNA, apenas um foi silenciado com sucesso. 




redução significativa da invasão de SGs pelos Plasmódios quando comparado ao controlo. 
No entanto, um incremento na expressão de α-Gal foi observado nesses SPZs. α-Gal não 
pôde ser detetado no ensaio de glinding dos SPZs e nenhum efeito no movimento dos 
SPZs foi observado quando encubados com mAbs anti-α-Gal ou lectina BSI-IB4. 
Conclusão: O antígeno α-Gal está presente em todo o ciclo esporogónio do Plasmodium, 
apresentando uma origem não exclusiva dos mosquitos. Os dados sugerem que α-Gal está 
envolvida na invasão da glândula salivar dos mosquitos, possível por meio da interação 
























Introduction: Understanding Plasmodium and mosquito vector interactions is crucial to 
develop strategies for control and malaria elimination in endemic areas. Mosquito’s 
salivary glands invasion is one of the most important steps for malaria transmission. 
Understanding how the Plasmodium parasite interacts with this organ is fundamental to 
achieve malaria elimination. Many glycans are implicated in cell-to-cell interactions and 
could play a central role in parasite-host interactions. The Galα1-3Galβ1-4GlcNAc-R 
glycan or simply α-Gal epitope is a major antigen for the human immunologic system and 
its present on Plasmodium, the malaria parasite.  
Aims: In this work, we aimed to understand the role of α-Gal during Anopheles spp. 
salivary glands invasion by Plasmodium and to establish the origin of Plasmodium α-Gal.  
Methods: To detect α-Gal immunofluorescence was used, Plasmodium bergei ANKA-
GFP sporozoites (SPZs), ookinetes, and oocytes were fixed with 4% paraformaldehyde 
and stained with the anti-α-Gal_IgG2b with secondary anti-mouse IgG conjugated with 
Alexa fluor-647, anti-CSP mAbs conjugated with Alexa fluor-647, or with Isolectin BSI-
IB4 conjugated with Alexa fluor-647. The α-Gal antigen was detected on mosquitoes’ 
midgut (MG) and salivary glands (SGs) by immunofluorescence microscopy and western 
blots. SPZs expressing α-Gal from infected An. stephensi collected from MG (8th to the 
23rd days post-infection), hemolymph (14th to the 23rd dpi), and SGs (14th to the 23rddpi) 
were detected and quantified using flow cytometry. The Plasmodium UDP-Gal 
transporter gene expression in SPZs from the MGs and SGs was accessed by RT-qPCR 
and the 2-ΔΔct at different days post-infection. The role of α-Gal on the Plasmodium 
mosquito interactions was investigated. Mosquitoes` UDP-Gal transporter and C-Type 
lectins (CTL)-galactose-binding genes were targets using RNA interference. The specific 
double-stranded RNA was injected on the 8th day post-infection. Gene silence was 
confirmed using RT-qPCR and at the 18th dpi, SGs and MGs were dissected and SPZs 
quantified by haemocytometer. The number of SPZs were compared with the control 
groups injected with unrelated dsRNA. The presence of α-Gal on SPZ gliding trial was 
investigated using anti-α-Gal mAbs conjugated with Alexa fluor-647. Additionally, the 
effect of anti-α-Gal mAbs and Isolectin BSI-IB4 on SPZs gliding movement was tested 
using live microscopic images. 
Results: The presence of α-Gal was detected by immunofluorescence microscopy in the 
mosquito’s midguts and salivary glands and on Plasmodium sporozoites and ookinetes. 
The percentage of SPZs expressing α-Gal, by flow cytometry at different days post-
infection showed a non-significant difference between them, but when SPZ from different 
organs (SG, HL, and MG) were compared, the SPZs from SGs presented significantly 
higher expression of α-Gal. The number of SPZs from SGs was reduced when mosquitoes 
UDP-Gal transporter gene was silenced while no differences were observed on the 
number SPZs from MG, but a reduced percentage of SPZs expressing α-Gal and lower α-
Gal intensity was observed in MG but not SG. From the three C-Types lectins (CTL)-
galactose-binding gene target with dsRNA, only one was successfully silenced. The 
silencing of the C-Types lectin (CTL)-galactose-binding gene resulted in a significant 
reduction of SGs invasion when compared with the control. However, an increment in α-
Gal expression was observed on those SPZs. α-Gal could not be detected on SPZs gliding 
trial and non-effect on SPZs movement were observed when SPZs were incubated with 




Conclusion: The α-Gal antigen is present throughout the Plasmodium sporogonic cycle, 
presenting a non-mosquito exclusive origin. The data suggest that α-Gal is involved in 
mosquito salivary gland invasion possible via receptor interaction but not via gliding.    
 




CHAPTER I: INTRODUCTION 
 
1. Malaria – Life history, epidemiology, and lifecycle 
Malaria is a vector-borne disease caused by an apicomplexan parasite belonging to 
Plasmodium genus transmitted by Anopheles mosquito’s bite (Cowman et al., 2016; 
Phillips et al., 2017). Considered one of the biggest public health problems worldwide, 
malaria caused more than 400,000 dead each year. Most of these deaths occur in children 
under 5 years, especially in developing countries (WHO, 2017; 2018; 2019; 2018). 
 
Almost half of the human population lives in risk areas for malaria, especially in Africa 
and Asia regions. The World Health Organization (WHO) in last malaria reported 
presenting an estimation of 228 million cases of malaria worldwide with the Africa region 
presenting 93% of all cases and almost 94% of all deaths in 2018. For this region, malaria 
control is one of the great challenges for public health (Global Malaria Programme: WHO 
Global, 2019).  
 
In the last 17 years, the number of new malaria cases is decreasing worldwide, due to an 
enormous global effort to eradicate the disease (Global Malaria Programme: WHO Global, 
2019). However, in 2017 some countries, mostly in Africa region, were registered a 
significant increase in malaria new cases (WHO, 2018). All these facts show that malaria 
should continue to be a top public health priority worldwide for the next decades (Varo 
et al., 2020). 
 
Drug resistance in malaria treatment (Hyde, 2005; Yeung, 2018), the lack of an effective 
vaccine against Plasmodium (Varo et al., 2020), regardless of the RTS, S/AS01 malaria 
vaccine already in phase III presenting consistent results (Agnandji et al., 2014), and the 
mosquito’s insecticides resistance (Schmidt et al., 2018) are greats changeling for all 
malaria control strategy, especially in high endemic zones. Because of that, the 
development of new control strategies and search for new targets seems to be very 
important for a effective malaria control.   




1.2 Malaria Etiology: Plasmodium life cycle   
Plasmodium is a genus of Apicomplexa parasites that infect vertebrates including 
primates, humans, birds, reptiles, and mice (Escalante & Ayala, 1995; Escalante & 
Pacheco, 2019). Different Plasmodium species infect humans and cause malaria, namely 
Plasmodium falciparum, Plasmodium. vivax, Plasmodium ovale, Plasmodium malariae, 
and Plasmodium knowlesi (Figure 1) (Cowman et al., 2016; Escalante & Pacheco, 2019). 
Nevertheless, Plasmodium species show similarities in their life cycles differences in their 
life cycle histories are present (Escalante & Pacheco, 2019; Hay et al., 2009). 
 
Figure 1: Plasmodium parasites groups based on the mitochondrial genome. 
Plasmodium species parasitic to humans, including those that cause zoonotic malaria (based on Escalante 
& Pacheco, 2019). 
 
Plasmodium parasites have a complex lifecycle, alternating between sexual reproduction 
stage in female Anopheles mosquitoes (definitive host) and an asexual reproduction stage 
in mammalian tissues (liver and blood) (Figure 2) (Aly et al., 2009; Center of Disease 
Control, 2017; Cowman et al., 2016; Ghosh & Jacobs-Lorena, 2009).  
 
After female Anopheles mosquito ingests an infective blood meal, inside midgut lumen, 





























microgametocytes (Aly et al., 2009) and these two gametes will fuse to generate a zygote 
(Figure 2) (Center of Disease Control, 2017; Ghosh & Jacobs-Lorena, 2009).  
 
Figure 2: Schematic representation of the complete Plasmodium life cycle on mosquito and the 
mammalian host. 
 (Center for Disease Control, 2017). 
 
The zygotes differentiate into ookinetes, a mobile form that traverses the mosquito´s 
peritrophic matrix and the midgut epithelium (Figure 2) (Aly et al., 2009; Angrisano et 
al., 2012; Vlachou et al., 2006). 
 
This elongate form (i.e ookinetes) invades the mosquito’s peritrophic matrix using 
chitinase and proteases, passed through midgut epithelium, and invades the basal lamina. 
Rhoptries and dense granules are not found in this stage, but micronemes are present. In 
ookinetes, micronemes are the only organelle associate with the secretion of cell surface-
associated or secretory proteins. During the midgut invasion process, ookinetes do not 
form a parasitophorous vacuole (Patra & Vinetz, 2012). Ookinest adheres to the luminal 




surface of the midgut, but not on the reverse side, which suggests the presence of a 
specific recognition mechanism for them in this side (Angrisano et al., 2012).   
 
Ookinetes preferentially attach via their apical tip to the mosquito's midgut cell 
membranes closely to adjacent cellular junctions and rapidly get to intracellular space 
(Whitten et al., 2006). Part of those ookinetes are destroyed by the mosquito´s immune 
system, via proteins that can cause parasite lyses or melanization generating the first 
bottleneck effect in the Plasmodium lifecycle (Angrisano et al., 2012; Clayton et al., 
2014). The remaining ookinetes will differentiate into oocysts, the only development 
stage that has extracellular growth (Angrisano et al., 2012).  
 
Oocysts get mature about 10-12 days with thousands of sporozoites (SPZs) forming inside. 
The oocyst suffers a disruption and SPZs egress into the mosquito´s hemolymph (HL) in 
a process still not clear. Eventually, they will invade the mosquito´s salivary glands (SGs) 
in a complex and selective way (Frischknecht et al., 2004; Ghosh and Jacobs-Lorena, 
2009; Mueller et al., 2010).  
 
SPZs released from oocysts invade exclusively SGs cells and the recognition process, by 
Plasmodium SPZs, is most likely via receptor-ligand interactions (Ghosh & Jacobs-
Lorena, 2009; Wells & Andrew, 2019). The overall picture for SPZs selection in SGs 
invasion remained unclear and, like in ookinetes, this stage generates a bottleneck effect 
on Plasmodium lifecycle, as not all SPZs will invade salivary glands (Aly et al., 2009).  
 
Once inside SGs ducts, the parasite is ready to start the vertebrate host cycle after being 
injected in a mammalian host (Aly et al., 2009; Ghosh & Jacobs-Lorena, 2009). 
Plasmodium sporogonic cycle, which occurs inside the mosquitoes, from gametocyte 
until SPZs arrives at SGs ducts, takes approximately 2-3 weeks in wild (Angrisano et al., 
2012).  
 




Mammalian hosts are infected with the Plasmodium parasite during an infectious bite 
when the mosquito ejects saliva containing a small fraction of SPZs present on SGs ducts. 
The SPZs are deposited in the dermis of the mammalian host and actively migrate passing 
through several skin cells into blood or lymphatic vessels to reach the liver (Frischknecht 
and Matuschewski, 2017, Aly, Vaughan and Kappe, 2009).  
 
Inside the liver, SPZs used endothelial or Kupffer cells to gain access to hepatocytes 
where they start a multiplication process producing thousands of merozoites, the only 
extracellular stage during the Plasmodium blood-stage infection (Figure 2) (Frischknecht 
and Matuschewski, 2017, Aly, Vaughan and Kappe, 2009).  
 
Merozoites formed on hepatocytes cells are released into the bloodstream (Cowman et al., 
2012) where red blood cells (RBCs) are invaded by a combination of four processes: 
passive diffusion, surface protein binding, actomyosin based movement, and membrane 
fusion (Farrow et al., 2011). The organelles microneme and rhoptry have an important 
role in this invasion process (Quintana et al., 2018). Once the parasite is inside the RBCs 
it forms a parasitophorous vacuole and a ring-like structure is formed (Cowman et al., 
2012; Farrow et al., 2011).  
 
Many parasites proteins are involved in the interaction between mammalian host cells 
and Plasmodium parasites such as merozoite surface protein 1 (MSP1) complex (Lin et 
al., 2014), circumsporozoite protein (CSP) (Aly et al., 2009; Singh et al., 2007), 
erythrocyte binding antigens (EBA) (Adams et al., 1992), cysteine-rich protective antigen 
(CyRPA) (Reddy et al., 2015) and apical membrane antigen 1 (AMA1) (Hodder et al., 
2001). The glycan protein CSP seems to be the most important of those proteins and 
playing an essential role in Plasmodium sporogony and liver stage (Aly et al., 2009; Weiss 
et al., 2016). 
The Plasmodium liver stage isn't associate with symptoms but, once the merozoites start 
invading RBCs and replicate exponentially the characteristic malaria symptom starts to 




appear. For P. falciparum each 48h, news erythrocytes are invaded by merozoites in a 
very fast (20s) and complex process (Quintana et al., 2018; Weiss et al., 2016).  
 
In some conditions, special on stress, some merozoites differentiate in female or male 
gametocyte that infects female Anopheles mosquito during the blood meal (Josling & 
Llinás, 2015; Milner, 2018), and inside the mosquitoes midgut those gametocytes will 
fuse and start the parasite sexual reproduction stage (Angrisano et al., 2012).  
  
1.3 Malaria Transmission: Anopheles and Plasmodium interactions 
Malaria epidemiology is influenced by many factors as local mosquito vector species 
(Alonso P. L. et al, 2011), transmission intensity (Mogeni et al., 2017), relapse behaviors, 
host risk factors, availability and efficacy of treatment, malnutrition, and prevalence of 
comorbidities (Howes et al., 2016). However, the presence of Anopheles is the most 
limiting factor (Alonso P. L. et al, 2011).   
 
Anopheles mosquitos' genus contained more than 500 recognized species and unclassified 
members with some species grouped and species complex (Hay et al., 2010). 
Morphologically, Anopheles mosquitoes are easily differentiated from other mosquitoes 
special when they are resting with the abdomen and head oriented in a straight line 
relating to the surface (Scarnecchia, 2004). Approximately 70 mosquito species, below 
to Anopheles genus can transmit Plasmodium parasite to humans, and from those 41 can 
transmit malaria at a level of public health concern. Anopheles mosquitoes are present all 
over the world, but more species are found in tropical regions (Rossati et al., 2016).  
 
The temperature is crucial for mosquito density which can influence malaria distribution 
(Rossati et al., 2016). Besides temperature, humidity and rainfall are conditions that most 
influence mosquito’s distribution with an impact on malaria transmission. Climate change 
can contribute to alter those conditions and could impact malaria transmission due to 
influences on mosquito habitat (Fouque & Reeder, 2019). 





Mosquito´s SGs are the ultimate target for pathogens that infect and replicate inside the 
female mosquitoes (Hardy et al., 1983; Mueller et al., 2010; Salazar et al., 2007). SGs in 
adult female Anopheles, are composed of a pair of glands with three lobes each (Figure 
3). They are located in the mosquito´s thorax on either side of the esophagus. The two 
lobes are acinar structures organized in a simple epithelium surrounded by a thin basal 
membrane immersed in mosquito´s hemolymph (Ghosh & Jacobs-Lorena, 2009; 
Moreira-Ferro et al., 1999; Wright, 1969). 
 
SGs have three secretory regions, proximal, distal, and medial one in each lobe. An extra-
acinar duct from the anterior part of each gland merges to form a common salivary duct 
(CD) that extends until the mosquito´s proboscis (Figure 3) (Moreira-Ferro et al., 1999; 
Wright, 1969). 
 
Female Anopheles SGs present a great variability of proteins with important roles in blood 
feeding and pathogens transmissions. Enzymes like apyrase and 5′-nucleotidase, salivary 
peroxidase, salivary serine proteases, antigen 5 family, D7 family, 30 kDa family, SG1 
family, cE5/anopheline family, SG2 family, and SG7 family proteins can be found in SGs 
just to mention a few (Arcà et al., 2017). 
 
Figure 3: Adult female Anopheles salivary glands scheme  








1.3.1 Anopheles SGs invasion by Plasmodium SPZs   
The process of Anopheles SGs invasion by Plasmodium SPZs is an essential step for 
parasite transmission from vector to the mammalian host (Aly et al., 2009; Mueller et al., 
2010). SGs invasion starts with the sporozoites attaching to the filamentous basal lamina 
using their anterior tip or in some cases, attaching along their entire length. SPZs 
associated with the basal membrane invade SGs secretory cells and reach the secretory 
cavities. During the invasion process, a transient parasitophorous vacuole is formed (an 
invagination from the epithelial cell membrane) which adopts the shape of SPZs while 
the thick CSP coat of Plasmodium is released. SPZs move from the secretory cavities into 
the larger central lumen and enters the salivary duct through the open terminus ( 
Figure 4) (Ghosh & Jacobs-Lorena, 2009; Wells & Andrew, 2019). 
 
Evidence shows that not all SPZs that invade SGs reach the secretory cavity and salivary 
ducts, most of them accumulate individually or in bundles, in cavities of secretory cells 
at the distal end of SGs lateral lobes. Mosquitoes SGs act as a barrier for Plasmodium 
SPZs creating a bottleneck effect in a way that from thousands SPZs that invaded SGs, 
10 to 100 are deposited into a mammalian host during probing (Frischknecht et al., 2004; 
Wells & Andrew, 2019). 
 
Figure 4: Scheme of SGs invasion by SPZs  














Morphologically Plasmodium SPZs present a crescent-shaped with 8 to 14 μm long and 
present substrate-dependent locomotion known as gliding motility (Figure 5) 
(Frischknecht and Matuschewski 2017; Kappe, Buscaglia, and Nussenzweig 2004). SPZs 
gliding allows the parasite to invade and pass through cells. As part of this process, SPZ 
adheres to the cells from host tissues (i.e. salivary glands epithelia, mammalian skin, liver 
sinusoidal cells, or hepatocytes) and this process can be mimic artificially on glass or 
plastic surfaces (Kappe et al., 2004; Santos et al., 2017). 
  
Figure 5: Three sporozoites move circularly with their apical end leading (red arrowheads). 
(Time between images is indicated in seconds and scale bar = 10μm) (based on Frischknecht & 
Matuschewski, 2017) 
 
Once SPZs are inside SGs they stop moving and aggregate within the salivary cavities 
where few of them move slowly down to the salivary ducts (Frischknecht & 
Matuschewski, 2017). The gliding motility seems to play an important role for these few 
SPZs that reach the wide portions of the primary duct and can be ejected during the 
mosquito’s salivation (Frischknecht et al., 2004; Vlachou et al., 2006).  
 
Many Plasmodium proteins are involved in gliding motility such as, actin filaments, and 
actin-binding proteins, including the motor protein myosin and a complex of myosin 
anchoring proteins that form a transient motor complex that integrates signaling proteins 
and molecules like calcium and possibly cAMP and cGMP (Frischknecht & 
Matuschewski, 2017; Kappe et al., 2004; Vlachou et al., 2006). 
 
During the SPZs gliding motility, the CSP and thrombospondin-related anonymous 
protein (TRAP) are secreted from the micronemes and, together with the Ca2+  and LIMP 
protein, are involved in the gliding and invasion process (Carey et al., 2014; Kappe et al., 
2004; Kebaier & Vanderberg, 2010; Santos et al., 2017). 
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Besides the gliding movement, SGs invasion by Plasmodium SPZs is mediated by ligands 
and receptors present on the parasite and SGs surfaces (Mueller et al., 2010). 
Carbohydrate molecules present on SGs surface appear to have a central role in the 
invasion process (Mueller et al., 2010). In Anopheles gambiae salivary glands, a protein 
named CSP-binding protein (CSPBP) that strongly interacts with CSP from SPZ was 
identified. CSPBP seems to has an important role in SGs invasion (J. Wang et al., 2013). 
On SPZs several proteins are involved in SGs invasion processes such as 
circumsporozoite protein (CSP), MAEBL, thrombospondin related anonymous protein 
(TRAP), Cysteine repeat modular proteins (PCRMP) and USO3, TREP/S6 (located in the 
plasma membrane) (Ghosh & Jacobs-Lorena, 2009).  
  
Since SGs invasion is mandatory for Plasmodium transmission, this phase is an important 
target for transmission-blocking strategies for malaria controls (Wells & Andrew, 2019), 
and highlighting limiting factors involved in this process can be very important.  
 
1.3.2 Anopheles midgut invasion by Plasmodium ookinetes 
The adult mosquito midgut (MGs) is composed of a single layer of polarized epithelial 
cells. The apical surface is formed by microvilli where digestive enzymes are secreted, 
and nutrients are absorbed.  In the basal pole, the basolateral membrane forms the basal 
labyrinth, an important structure for molecular exchanges and water and ion transport. 
The cells are connected through their lateral borders smooth septate junctions, acting like 
mechanical linkages or by gap junctions (Baia-da-silva et al., 2019; Hecker, 1977; 
Whitten et al., 2006).  
 
SPZs and ookinetes are motile forms of the malaria parasite and despite the 
morphologically and distinct target cells, they share the same core components of gliding 
motility apparatus (Santos et al., 2017). Plasmodium ookinetes actively invade Anopheles 
MGs using the secretory organelles and the apical conoid structure in the invasion process. 
Micronemes, present in the apical structure, and microtubules permit ookinetes to 
recognize and penetrate the MG epithelial cells (Angrisano et al., 2012; Patra & Vinetz, 




2012). Micronemes are organelles for cell surface-associated secretion, having different 
secretory proteins, such as CSP and TRAP-related protein (CTRP), chitinase, and WARP 
(Patra & Vinetz, 2012). 
 
Ookinete MG´s invasion starts by crossing the peritrophic matrix and actively entering 
the epithelial cell (Mueller et al., 2010; Patra & Vinetz, 2012). The ookinete egress the 
epithelial cells at the basal site, which is accompanied by lamellipodia formation in the 
invaded cell as well as its neighbors. In the extracellular space of the basal labyrinth, the 
ookinete starts to round up beneath the basal lamina and transforms into the oocyst. The 
invaded midgut cells undergo many severe physiological changes, becomes apoptotic, 
and  expelled from the epithelium (Figure 6) (Angrisano et al., 2012; Mueller et al., 2010).   
 
The microneme proteins CTRP, SOAP, WARP and CHT1, MAOP are factors involved 
in adhesion, motility, and invasion present in ookinetes. Additionally, surface proteins 
like S6/TREP/UOS3, TLP, PCRMP1, PCRMP2, TRSP-the rhoptry-resident proteins, 
RON4, CSP-the GPI-anchored CSP are also involved (Santos et al., 2017) in this process.  
 
Figure 6: Schematic representation of ookinetes midgut epithelial invasion process. 
Arrow –ookinete and Mv - mosquito midgut microvillar epithelium 















2. Role of glycans on Plasmodium and invertebrate host interaction  
Mosquitoes and parasite interactions are mediated by multiple molecules in the different 
life cycle stages. The interaction with SGs is particularly important as it might determine 
the outcome of the transmitting processes and being an excellent target for developing 
transmission-blocking strategies (Aly et al., 2009; Birkholtz et al., 2016; Ghosh & Jacobs-
Lorena, 2009; Goncąlves & Hunziker, 2016; Schleicher et al., 2018). 
 
The interaction between the malaria parasite and hosts are mediated by glycans that can 
be found decorating both Plasmodium and host cells surface. Because of that, such 
molecules can be good therapeutic targets, special for vaccines (Gomes et al., 2017; 
Sampath et al., 2013; von Itzstein et al., 2008) or transmission-blocking approaches 
(Birkholtz et al., 2016). For instance, blocking the biosynthesis chain of 
glycosaminoglycan on mosquitoes MGs microvilli strongly affects the development of 
Plasmodium (Dinglasan et al., 2007). 
 
2.2 The glycosylation processes 
The process of glycan synthesis is a complex non-template-driven process that, involves 
more than 200 enzymes. The presence of glycan structures is so important that defective 
or complete loss of lipid and protein glycosylation is lethal for all metazoans (Cosgrave 
et al., 2011; Stanley & Cummings, 2017).  
 
Glycan structures have important biological and physiological roles contributing to 
protein folding, quality control, and a large number of biological recognition events 
(Moremen et al., 2012). The most common types of glycosylation are the large branched 
glycans covalently linked to asparagine amino acid residues (N-glycans), the smaller 
linear and/or biantennary glycans linked to serine or threonine amino acid residues (O-
glycans), and linear-sulfated glycans bound to serine (Cosgrave et al., 2011). 
 




In the glycosylation process, sugars are covalently attached to nascent proteins, lipids, or 
the growing end of glycan chains by several glycosyltransferases (Moremen et al., 2012). 
This process is considered the most complex and frequent post-translational modification 
that occurs on proteins (Hadley et al., 2019), determining the solubility, activity, stability, 
and molecules localization (Cosgrave et al., 2011) which play important roles in every 
aspect of cells biology (Hadley et al., 2014, 2019).  
 
Most protein posttranslational modifications, mainly sulfation, phosphorylation, and 
glycosylation take place in the Golgi lumen and Endoplasmic Reticulum (ER). In the 
glycosylation process nucleotide sugars (i.e. activated sugar forms, like Uridine 
diphosphate galactose - UDP-Gal) are transported into the Golgi lumen ( Liu et al., 2010). 
 
2.3 Nucleotide sugar transporters (NSTs) 
The activated sugar forms are transported by transmembrane proteins denominated 
nucleotide sugar transporters (NSTs) (Hadley et al., 2019). NSTs are proteins that provide 
a link between the glycosylation processes that take place in the Golgi and ER lumen and 
the synthesis of nucleotide sugars that occurs in the ER, nucleus, or cytosol. They are 
highly conserved type III transmembrane proteins (Hadley et al., 2014).  
 
NSTs play a fundamental role in the biosynthesis of glycoproteins and glycolipids, 
mediating the translocation of nucleotide sugars from the cytosol to the Golgi lumen and 
serving as sugar donors for glycosyltransferases enzymes, (Cosgrave et al., 2011; Hadley 
et al., 2019; L. Liu et al., 2013). The CMP-Sialic acid transporter (CST), UDP-Gal 
transporter (UGT), UDP-GlcNAc transporter (NGT), PAPS transporter 1 and 2, UDP-
Xyl transporter (YEA), GDP-Fuc transporter (GFT), and GDP-Man transporter (HFRC1) 
are examples of NSTs found in eukaryotic cells (Hadley et al., 2014; L. Liu et al., 2010). 
 
It is hypothesized that NSTs act by pumping activated monosaccharides from the cytosol, 
into the organelle lumen and in the opposite direction, the corresponding monophosphate 
and the product of glycosylation reaction (Figure 7) (Hadley et al., 2014; Sosicka et al., 




2019). The exchange of cytosolic nuclear sugar for the corresponding luminal nucleotide 
monophosphate occurs via NST in a way that the nucleotide sugar level in Golgi or ER 
lumen is constant (Figure 7) (Hadley et al., 2014).  
Deflections or mutation on specific NSTs genes can result in defects in glycoconjugates 
that contain the corresponding sugar. NSTs can regulate the glycosylation of 
macromolecules (Cosgrave et al., 2011; L. Liu et al., 2013), e.g., deficiency in UDP-Gal 
transporter (UGT) in mutant Madin-Darby Canine Kidney (MDCK) cells line shows 
reduction on galactosylation in glycoproteins, glycosphingolipids, and proteoglycans (Liu 
et al., 2010). 
 
Figure 7: Schematic representation of the general transport mechanism of NSTs. XDP - diphosphate 
nucleotide; XMP – monophosphate nucleoside  
(Adapted from Hadley et al., 2014). 
 
Endogenous NSTs and glycosyltransferases have a proximity interaction (Maszczak-
Seneczko et al., 2015), and the idea that they form a multi-proteins complex structure for 
the glycosylation process, has been reinforced (Hadley et al., 2019; Khoder-Agha et al., 
2019). The proximity of UGT, UDP-GlcNAc transporter (NGT), and 
acetylglucosaminyltransferase suggest the formation of multi-protein complexes that 














2.3.1 UDP-Gal transporter and α-1,3GTenzyme in α-Gal epitope 
synthesis 
Uridine-5´-diphosphogalactose galactose (UDP-Gal) is a nucleotide sugar that is 
translocated from the cytosol into the Golgi lumen by the nucleotide sugar transporters 
UDP-galactose transport (UGT). This NST is strongly present on the Golgi complex 
(Benau et al., 1990; Hudson H. F., Gerald W. H., 2017) and can be formed in three ways: 
(1) from a direct phosphorylation reaction to a galactose-1-P, witch reacts with UTP; (2) 
from the action of uridyl transferase exchange on UDP-Glc, displacing the glucose-1-P 
to Gal and/or (3) the action of NAD-dependent reaction catalyzed by UDP-Gal 4 
epimerase (Hudson H. F., Gerald W. H., 2017). 
 
The presence of UGT is central for galactosylated glycoconjugates synthesis that takes 
place in Golgi lumen mediate by galactosyltransferase (Hudson H. F., Gerald W. H., 
2017; Sprong et al., 2003). Cells that lack UGT in the Golgi, present a decreased capacity 
to add Gal to glycans structures (Hadley et al., 2014), e.g., knocking down the gene that 
codes for UGT in Golgi of Madin-Darby Canine Kidney (MDCK) cells result in a 
significant decrease in the galactosylated process during glycoproteins and glycolipids 
synthesis (Hudson H. Freeze, Gerald W. Hart, 2017).  
 
Drosophila melanogaster UGT protein, localized in the Golgi region, transports both 
UDP-Gal and UDP-GalNAc (Segawa et al., 2002). The transport of these two nucleotide 
sugar is fundamental for the synthesis of Galα1-3Galβ1-4GlcNAc-R (α-Gal) epitope (X. 
Chen et al., 2002), which is the main subject of our present study.  
 
The α-Gal epitope structure is a carbohydrate chain, with no folding or tertiary structures 
and with robust stability (Wigglesworth et al., 2011). Its present a conserved structure 
across invertebrates, fish, amphibians, reptiles, and mammal species (Shao et al., 2012). 
It's present on the glycolipids and glycoproteins surface from different pathogens 
including the malaria parasite (Almeida et al., 1993; Krumm; & Doores, 2018; Portillo et 
al. 2019; Yilmaz et al., 2014).  




The formation of glycan structures in the biological system involves the activation of a 
monosaccharide by attaching it to a nucleotide, that works as a sugar-nucleotide donor 
for an acceptor to form an elongated sugar and a nucleotide by-product (X. Chen et al., 
2002), as previously discussed.  
 
The α-Gal epitope is synthesized on type-2 units on glycolipids and glycoproteins by a 
specific α1-3 galactosyltransferase enzyme (i.e. α-1,3GT). The type-2 unit can be 
generated from complex N-glycan (anchored in Aspargine), O-glycan (anchored in 
Serine/Threonine), or NeoLacto glycolipid (anchored in Ceramide) core structures when 
receiving an β1-4Gal, by the action of β1-4 galactosyltransferase (i.e. β-1,4GT), to form 
a Galβ1-4GlcNAc, also called N-acetyllactosamine (LacNAc) (Figure 8) (Blanken & 
Eijnden, 1985; Stanley & Cummings, 2017).  
 
Figure 8: Structure and synthesis of the Galα1-3Gal antigen. 
The α1-3GT adds a Gal terminal on Type-2 units present in glycoproteins or glycolipids (R) to form the 
α-Gal terminal epitope (Adapted from Stanley & Cummings, 2017). 
 
Together, β-1,4GT and α-1,3GT can elaborate the terminal Galα1-3Galβ1-4GlcNAc-R, 
or simply α-Gal epitope, that can occur on glycoproteins and glycolipids (Blanken & Van 
Den Eijnden, 1985). The α-1,3GT is a Golgi enzyme that uses the UDP-Gal as a donor, 
catalyzing the transference of a Gal from the nucleotide sugar to 4-OH terminal of 
GlcNAc residues to produce the α-Gal epitope and related structures (Boix et al., 2002; 
X. Chen et al., 2002; Galili, 2013a; Joziasse et al., 1990; Khraltsova et al., 2000; 
Takayama et al., 1999).  




In this process, the donor-substrate (i.e. UDP-Gal) binds before the acceptor-substrate in 
an obligatory order (Boix et al., 2002). The enzyme α-1,3GT, in its crystal structure, 
present an aromatic side chain (Trp249) where the acceptor GlcNAc binds the 
monosaccharide ring in its non-polar surface (Boix et al., 2002). 
 
Glycosyltransferases (GTs) present a high specificity to the donor and acceptor (Chao 
Chen et al., 2016), with α-1,3GT presenting very low activity for N-acetylglucosamine 
(GlcNAc), but high activity in the presence of acceptors carrying a terminal Galβ1-
4GlcNAc unit (Blanken & V. D. Eijnden, 1985), indicating its high specificity for this 
acceptor.  
 
2.3.2 α-Gal epitope immunogenicity propriety 
The terminal sugars of mature glycan are often involved in regulatory functions or 
recognition of glycoconjugate (Esko., 2017) and they could be the target of immune 
responses, mediated by cells or immunoglobulin (Varki, 2006; Wigglesworth et al., 2011).  
 
The α-Gal epitope is universally present in non-primate mammals, marsupials, and new 
world monkeys, but is absent in humans, apes, and old-world monkeys. This absence is 
related to a mutation in the α-1,3GT gene that generates a premature stop codon and the 
enzyme truncation (Galili, 2013a; Huai et al., 2016). The selection of such mutation in 
Old World primates, including humans, appeared to result from what seems to have been 
a great catastrophic epidemiological event (Galili, 2013b).  
 
In human sera, a large amount of natural antibody against α-Gal that recognize 
specifically the α-Gal epitope is found (Galili, 2013b; Huai et al., 2016) representing 
almost 1% of total immunoglobulin’s (i.e. Igs) or 1-5% if considering only circulating 
IgM and IgG in an immune-competent human (Cabezas-Cruz et al., 2015; Galili, 2013a).  
 




Different classes of antibody against α-Gal epitope including IgM, IgG, IgA, IgE, and 
different IgG isotypes (IgG1, IgG2a, IgG2b, and IgG3) are found in human sera (Ding et 
al., 2008; Galili, 2013a; Yu et al., 1999), and after α-Gal epitope stimulation in a 
competent immune system, a dramatic increase in anti-α-Gal antibodies productions is 
observed (Yu et al., 1999).  
 
Because the antibodies against α-Gal are so abundant in healthy human sera, it can be 
used for various clinical purposes (Galili, 2013a) such as xenotransplantation using α1,3-
GT Knockout pigs, the immunogenicity of tumor vaccines (i.e. cancer immunotherapy), 
increase the efficacy of new or existent vaccines, tissues regeneration (Galili, 2013b; Huai 
et al., 2016) or to target vector-borne diseases agents (Cabezas C. et al., 2016; Yilmaz et 
al., 2014). The α-Gal epitope induces via anti-α-Gal antibodies, rapid recruitment, and 
activation of macrophages with is a central role in regeneration processes (Huai et al., 
2016; Wigglesworth et al., 2011).  
 
The α-Gal has been considered the major barrier in xenotransplantation processes (Galili, 
2013a), being responsible for hyperacute rejection (HAR) of xenotransplanted organs 
(Ding et al., 2008) a process mediated by complement activation induced directly by 
antibodies or by cellular responses via Fcγ receptor (i.e. FcγR)  (Ding et al., 2008; 
Wigglesworth et al., 2011).  
 
In humans, anti-α-Gal antibodies, are involved in processes that can result in an allergenic 
reaction, even anaphylactic shock, mediated by IgE antibodies, special after beef or pork 
consumption (Galili, 2013a). Allergies to red meat related to the α-Gal epitope show great 
correlation with prior tick bites which may express α-Gal in the saliva (Stanley & 
Cummings, 2017). Moreover, if by some genetic disorder α-Gal or a mimetic peptide are 
expressed in tissues, the immune systems start an autoimmune response, as found in 
Graves` disease (Galili, 2013a).  
 




Antibodies against α-Gal epitope are produced in response to continuous antigenic 
stimulation by gastrointestinal bacteria (Galili, 2013a; Stanley & Cummings, 2017) 
leading experts to propose the use of probiotics composed of highly expressing α-Gal 
bacteria as a possible strategy for vector-borne diseases (VBDs) control (Cabezas Cruz et 
al., 2016) including malaria (Yilmaz et al., 2014) and Chagas disease (Portillo et al., 
2019). 
 
2.4 Mosquito’s glycosylation process 
Insect cells can produce N- and O-glycans with similar core structure to mammalian cells 
(Cosgrave et al., 2011) with O-glycans present in insects showing less diversity than 
mammalian cells (Lopez et al., 1998). Most of this glycans structure is compost by eight 
monosaccharides as galactose (Gal), glucose (Glc), mannose (Ma), xylose (Xyl), fucose 
(FuC), GalNAc, N-acetylglucosamine (GlcNAc), glucuronic acid (GlcA), and sialic acids 
(SA), and mannose being the most imported insect  monosaccharide involve in the 
glycosylation process (Vandenborre et al., 2011; Walski et al., 2017). 
 
Complex glycans modified with the addition of GlcNAc, GalNAc, Gal, and SA residues 
occur in a minor fraction of insect N-glycans when compared to vertebrate, but still, these 
glycans appear to play important roles in insect physiology (Walski et al., 2017).  
 
Lectins are proteins with high affinity to specific monosaccharides (Gerke & Plenderleith, 
2002) that are being used to detect glycans on the surface or inside biological structures, 
with a high level of specificity in mosquito tissues (Mohamed & Ingram, 1993; Rudin; & 
Hecker, 1989; Wilkins & Billingsley, 2001, 2010).  
 
A study using different lectins (SBA, HPL, LFA, RCA I, SBA, UEA I, and WGA) that 
target different polysaccharides including α/βGal (RCA I and SBA) on Aedes aegypti and 
An. stephensi midgut shown that the large majority of biding structures, i.e. glycosylation 
structures, were present on the midgut epithelium microvilli and peritrophic membrane 
but not in the intracellular space (Rudin; & Hecker, 1989). Whereas, An. stephensi and 




An. gambiae cell lines displayed a limited range of glycoproteins when compared with 
midgut epithelium (Wilkins & Billingsley, 2010).  
 
Mosquitoes midgut microvillar glycoproteins expressing oligomannose and/or hybrid N-
linked oligosaccharides, glycoproteins with α-1,6 linked fucose as core residues, O-linked 
glycan contained terminal GalNAc with fucose and/or Gal were detect using lectins 
(Wilkins & Billingsley, 2001). A similar approach, using several lectins showed the 
presence of mannosyl moieties, GlcNAs, Gal, galactosyl moieties, and Ma on the surface 
of Anopheles salivary glands (Mohamed & Ingram, 1993).  
 
Glycan molecules present on the SGs surface play an essential role in the parasite invasion 
process since they serve as receptors (Ghosh & Jacobs-Lorena, 2009; Molyneux et al., 
1990; J. Wang et al., 2013), e.g., a polyclonal antibody (IgG fraction) against SGs (Ae. 
aegypti) basal lamina and lectins can block Plasmodium sporozoites SG invasion  
(Barreau et al., 1995) highlighting the importance of glycans on this process.  
 
2.5 Mosquitoes Lectins 
Lectins are proteins/glycoproteins that binding a great variety of carbohydrates in a 
specific way and present the ability to induce red blood cells (RBCs) agglutinations 
(Sharon et al., 1972). Lectins can be found either in animals, plants, or microorganisms 
and are involved in a large variety of recognition cellular processes, such as cell-cell and 
host-pathogen interaction, turnover serum glycoproteins, and part of the innate immune 
response (Kennedy et al., 1995; Vijayan & Chandra, 1999). 
  
Structurally lectins present great variability (Loris, 2002), and basing on this variability, 
it´s possible to distinguish five types: legume lectin, C-lectin, I-lectin, P-lectin, and b-
propeller. The different lectin types corresponding to different carbohydrate-binding 
motifs (Vijayan & Chandra, 1999).  
  




In insects, lectins are part of the immune system and act specially on microorganism 
invasion (Natori, 2001; Theopold et al., 1999). The galactose binding C-type lectins 
(CTLGA) are very common in insects and are implicated in the immune response. They 
are proteins that bind carbohydrates through the C-terminal recognition domain in the 
obligatory presence of Ca2+. In An. gambiae genome, 23 genes coding for C-type lectin 
are already identified (Cirimotich et al., 2010; Natori, 2001). 
 
C-type lectins are part of the innate immune system of mosquitoes by recognizing and 
binding with glycans structures. The CLT4 and CLTMA2 are proteins that belong to C-
type lectins with their genes being conserved between Anopheles species. These lectins 
act as inhibitors of mosquitoes' melanization process in the immune response to the 
Plasmodium parasite (Bishnoi et al., 2019).  
 
C-type lectins present an important role in the mosquito response against Plasmodium 
infection and if their expression is down regulated a significant increase in Plasmodium 
melanization is observed and a consequent reduction in parasite number (Cirimotich et 
al., 2010; Osta, Christophides, & Kafatos, 2004). 
 
C-type lectins, special CLT4, and CLTMA2 can bind Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
sp2 and Galβ1-4GlcNAcβ1-3(Galβ1-4GlcNAcβ1-6)GalNAcα-sp3 and other glycans 
(Bishnoi et al., 2019). Is good to remember that the Galβ1-4GlcNAc is implicated in the 
α-Gal epitope formation (Stanley & Cummings, 2017) and this can point to a relation 
between lectins that binding with Gal terminal like α-Gal epitope.  
 
In other mosquito species ( e.g. A. aegypti)  galactose specific C-type lectins (CTLGA) 
are present on salivary glands (Y. Liu et al., 2014), and most of them are implicated in 
interaction between the mosquito and arbovirus in a manner that helps the virus infection. 
Orthologous genes for proteins that contained C-type lectins domain are found in A. 
gambiae (Adelman & Myles, 2018; Y. Liu et al., 2014).  
 




Other lectins like mannan-specific lectins (MBL) have been described in An. stephensi 
female. The MBL erythrocytes agglutination activity is inhibited in the presence of 
mannan and nitrophenol-modified sugar, but the activity was not inhibited by a single 
glycan like Galactose. The MBL, as C-type lectins, is Ca+2 dependent (Changlin Chen & 
Billingsley, 1999). 
 
2.6 Glycan’s from pathogens 
Glycan structures found on protozoan and helminthes parasites are generally different 
from those found in vertebrates. Parasite glycan structures are typically antigenic and they 
are involved in host interaction/invasion by glycan-binding proteins (GBPs) that interact 
with host glycans and parasite glycans that interact with host GBPs and antibodies 
(Richard D. Cummings & Die, 2017).  
 
Endogenous antibodies that recognize carbohydrate epitopes can protect from infection 
by pathogens that carry such epitopes (Galili, 2013a; Portillo et al., 2019; Yilmaz et al., 
2014). Combined with carrier proteins, glycan structures can induce high immunogenicity 
in a host infected by a parasite with long-lasting protection. Because of their 
immunogenic characteristics, carbohydrate-based vaccines from different pathogens (i.e. 
virus, bacteria, fungus, and parasites) have been proposed (Krumm; & Doores, 2018). 
 
The development of an effective Plasmodium vaccine is still a challenge that persists. 
MosquirixTM (RTS,S by GSK) is one of the most advanced pre-erythrocytic vaccine 
candidates, targeting the circumsporozoite protein (CSP). CSP is the major protein found 
on Plasmodium SPZs surface, attached to the plasma membrane via a GPI anchor (Todryk 
& Hill, 2007). GPI anchor, which contains multiple mannose residues, glucosamine, and 
6-myoinositol-1,2-cyclic phosphate, is another glycoprotein vaccine candidate based on 
carbohydrate recognition (Krumm; & Doores, 2018).  
 
Plasmodium merozoites, SPZs, and ookinetes all possess a glycocalyx with 5-20 nm with 
numerous glycoproteins. In sporozoites, the glycocalyx is dominated by the CSP (Sinden, 




1985). Glycan structures on Plasmodium are believed to be limited to GPI anchors like in 
CSP and TRAP proteins ( Yilmaz et al., 2014; von Itzstein et al., 2008), but due to the 
complexity of the biologic glycosylation process and the carbohydrate complexity and 
heterogeneity, many aspects of glycobiology remains unclear (Cosgrave et al., 2011). 
 
2.6.1 Pathogens α-Gal epitope  
The epitope α-Gal is present on the surface of Plasmodium and due to its high 
immunogenicity to humans is a vaccine candidate with the potential to protect against 
other vector-borne protozoan parasites that express this same glycan (Yilmaz et al., 2014; 
Krumm; and Doores, 2018). Antibodies again α-Gal present on Plasmodium SPZs 
provided sterile protection against malaria in infected mice (Soares & Yilmaz, 2016; 
Yilmaz et al., 2014).  
 
The α-Gal has also been detected on Trypanosoma cruzi (Almeida et al., 1994) and led to 
the development of an α-Gal-based glycovaccine against Chagas disease (Portillo et al., 
2019). 
 
On T. cruzi the α-Gal epitope seems to be associate with GPI-anchor (Almeida et al., 
1994; Portillo et al., 2019), the same seems to occur with the Plasmodium α-Gal epitope, 
as when sporozoites are treated with phospholipase C (PLC), that cleaves GPI, the α-Gal 
expression is reduced 4 fold  (Yilmaz et al., 2014). It´s important to mention that, despite 
the presence of α-Gal on Plasmodium sporozoites surface, the parasite lacks many 
enzymes such as glycosyltransferase commonly found in other protozoa (Yilmaz et al., 
2014; von Itzstein et al., 2008).  
 
The presence of α-Gal on parasites is further corroborated as parasites such as T. cruzi or 
Plasmodium sp. stimulate the immune system to produce high titers of anti-α-Gal in 
Malaria and Chagas patients (Galili, 2013a; Portillo et al., 2019; Yilmaz et al., 2014). 
Antibodies against α-Gal epitope, mediate a lytic activity in T. cruzi blood forms via the 
classic or the alternative complement pathways (Gazzinelli et al., 1991).  Similarly, when 




Plasmodium SPZs were exposed to a specific antibody against α-Gal epitope they were 
destroyed via the complemented system (Yilmaz et al., 2014). 
 
Another example is the agent of cutaneous leishmaniasis, Leishmania major, that presents 
α-Gal on its surface and using α1,3GalT-KO mice challenge with α-Gal epitope a high 
level of antibodies are produced, special IgG isotypes and IgE, giving partial protection 
again L. major in a posterior infection on these α1,3GalT-KO mice (Iniguez et al., 2017).  
 




3. CENTRAL QUESTION:  
 
What is the role of α-Gal on sporozoite invasion of salivary glands and transmission? 
 
4. HYPOTHESES 
 The amount of α-Gal on the sporozoite varies with the progression of the 
sporogonic cycle; 
 
 The α-Gal present on Plasmodium spp. sporozoites have a mosquito origin; 
 
 The α-Gal epitope is involved in mosquito salivary glands' invasion during 
mosquito infection.  
 
5. THESIS AIMS: 
 
 To determine the dynamics of α-Gal expression on the parasite surface during the 
sporogonic development of Plasmodium berghei (ookinetes, oocysts, and 
sporozoites); 
 
 To characterize the amount of α-Gal present on Plasmodium sporozoites surface 
from mosquito´s midgut, hemolymph, and salivary glands; 
 
 To establish the origin of α-Gal on the parasite, if it comes from the parasite itself 
or if it has a mosquito origin; 
 
 To establish the role of the α-Gal epitope in sporozoite salivary glands invasion.   
 
 

















































CHAPTER II: METHODS 
 
1. Mosquito’s colony 
For all experiments were used Anopheles stephensi mosquitos’ colonies established at 
Instituto de Higiene e Medicina Tropical (IHMT/UNL) and adults were fed ad libitum 
with a 10% sucrose solution. Mosquito’s colonies were maintained under a 12:12 hour 
light/dark cycle at 26ºC and 70-80% relative humidity, and at 21ªC after Plasmodium 
berghei infection (Félix & Silveira, 2011).  
 
2. Parasite strain 
A transgenic Plasmodium berghei ANKA strain expressing green fluorescent protein 
(GFP) throughout their lifecycle under the EEF1 α promoter (PbAEEF1αGFP) was used in 
all experiments. P. berghei infected red blood cells (1x106) (RBC) were injected 
intraperitoneal (i.p.) into BALB/c mice and the infections were monitored for the 
presence of gametocyte-stage parasites in blood smears, stained with Giemsa (Merck). 
Infected mice were anesthetized with 125 mg/kg ketamine and 12.5 mg/kg xylazine given 
i.p. and used to feed 3 to 4-day-old A. stephensi female mosquitoes. Mosquitoes fed with 
infected blood were maintained at 21ºC and 75% of relative humidity to promote the 
complete sporogonic cycle (Félix & Silveira, 2011; Franke-Fayard et al., 2004). 
 
3. Cells strain  
The An. gambiae cell line 4a3a, 4a3b, and SAU51 were maintained with Schneider’s 
medium (Biowest®) supplemented with 10% heat-inactivated FCS (Sigma) and 
100U/mL Pen.+100ug/mL Strep (Sigma) in 75 mL flasks at 27 ºC without CO2 (Annex 
IV).   
 
4. Mosquito’s dissection and sporozoite collection 
A. stephensi infect with P. berghei were selected under a fluorescent microscope (10X 
magnification; Axioskop zeiss, ProgRes® C12plus). Mosquitoes were cold anesthetized 




(2-3 min at -20º C) and quickly passed through ethanol 70% and washed on 1X phosphate 
buffer solution (PBS) (VWR). Mosquitoes were dissected in a small drop of PBS on a 
glass slide using two needles, under a stereomicroscope (3X magnification; Nikon 
SMZ800). Midguts (MG) were collected at the 8th, 10th, 12th, 14th, 16th, 18th, and 23rd day’s 
post-infection (dpi) and salivary glands (SG) at the 14th, 16th, 18th, and 23rd dpi, or just at 
the 18th for gene silencing experiments. 
 
For each time point, 25-30 SGs and16-30 MGs were collected in LoBind microfuge tubes 
(Eppendorf) containing 75μL of sterile PBS 1X. Samples were mashed using a Pellet 
Mixer (VWR) for 25-30sec, to release SPZs and filtered through a filter-tube-35µm-mesh 
(Corning™ Falcon™ Test Tube with Cell Strainer Snap Cap).  
 
SPZs from hemolymph were collected using a modified method proposed by M. 
Kambysellis (Hedrock, 1984). Mosquitoes were pricked in the thorax with a 30 Gauge 
needle at 14th; 16th; 18th and 23rd dpi. Pools of 25-30 mosquitoes were placed in 0.5 mL 
microcentrifuge tubes, with the bottom previously perforated, and placed inside 1.5 mL 
LoBind microfuge tubes (Eppendorf) and centrifuged (Eppendorf Centrifuge 5417C, 5 
min; 400g).  
 
SPZs were fixed with 4% w/v paraformaldehyde for 20-30 min (Alfa Aesar, 
ThermoFisher) and washed once with PBS. The KOVA Glasstic Slide 10, with counting 
grids (ThermoFisher Scientific), was used for SPZs counting. 
 
5. Plasmodium berghei ookinetes culture  
Infected blood with P. berghei (PbAEEF1αGFP) from BALB/c mice was extracted, via 
cardiac puncture, and then immediately added to ookinete medium containing RPMI, 
10.4g/L; NaHCO3, 2g/L; HEPES, 25mM; Xanthurenic acid, 100μM; Penicillin, 50U/mL; 
Streptomycin, 50μg/mL; Fetal Bovine Serum (FBS) 20% at pH 7.4 (all reagents from 
Sigma) at Room Temperature (RT) and a hematocrit of 1.3-2.5 RBC/mL. Parasites were 
incubated at 21ºC for 24 hours in soft orbital agitation (100 rpm). The presence of 




ookinetes was confirmed by fluorescent microscopy and smears stained with Giemsa 
(Merck) (Marques et al., 2017; Rodríguez et al., 2002).  
 
6. CSP and α-Gal detection on P. berghei and mosquito tissues by 
immunofluorescence 
Infected A. stephensi SGs and MGs, and P. berghei ookinetes and SPZ were placed 
directly on a diagnostic PTFE slide (25x75x1mm, 3 Black Wells 14mm, Thermo 
Scientific) and fixed with 4% w/v paraformaldehyde for 20-30 min (Alfa Aesar, 
ThermoFisher). Samples were gently washed once with PBS and incubated overnight 
with 10µL of anti-CSP IgG (10µg/mL) or anti-α-Gal IgG2b (50 µg/µL) or Alexa Fluor® 
647 conjugated Bandeiraea (Griffonia) simplicifolia - I isolectin IB4 (100µg/mL; BSI-
IB4, Invitrogen) at 4º C in dark in a humid chamber. Except for BSI-IB4 stained slides, 
samples were gently washed with PBS and incubated with 10μL of a secondary 
conjugated antibody (Alexa Flour® 647 Goat Anti-Mouse IgG-H+L; 1:1000; Molecular 
Probes®). Slides were incubated at RT in dark for 1-2 h. Samples were gently washed 
with PBS and mounted with VECTASHIELD containing 4′,6-diamidino-2-phenylindole 
(DAPI; Vector Laboratories, Inc.) and observe under the fluorescent microscope (Nikon, 
Eclipse 80i, CameraDS-Ri1, with software NIS-Elements BR 3.2), using GFP, Cy5, and 
DAPI filters under 40 or 100X magnification. ImageJ 1.52n software 
(https://imagej.nih.gov/ij/) was used to marge channels and create composite images. 
Anti-CSP and anti-α-Gal mAbs were kindly provided by Miguel Soares laboratory 
(Instituto Gulbenkian de Ciência, Portugal). 
 
7. Mosquitoes’ α-Gal detection by western blot 
Batches of 70-80 mosquitoes SGs and MGs from infected (16-18dpi) and non-infected 
mosquitoes were collected, dissected, placed in a 1.5 ml Eppendorf tube with 100µl of 
PBS, and stored at -80 ºC until used. Samples were mashed for 25 to 30sec using a Pellet 
Mixer (VWR) and 40µl of lysis buffer (Tris, 50mM; NaCl, 150 mM; Triton X-100, 1%; 
Protease inhibitor cocktail 1X, Roche Diagnostics GmbH at pH 7.5) was added and 
incubated on ice for 1h30min.  
 




Samples were centrifuged at 14000g for 5 min at 4º C and the supernatant was collected 
to a new tube with 12.5µL of loading buffer (Laemmli 4X in Stock) and 2-
Mercaptoethanol (Merck) at the final concentration of 2.5%. Samples were incubated at 
95ºC for 5 min (thermo-block ECN: 460-0196). Twenty-five µL of each sample and the 
molecular weight marker (Precision Plus Protein™ Dual Xtra Prestained Protein 
Standards) were loaded onto an SDS-PAGE gel.  
 
Electrophoresis was performed on running buffer (Tris, 25mM; glycine, 190 mM; 0.1% 
of SDS) for 10 min at 60 volts, followed by 1h10min at 120 volts. Using a transfer buffer 
(Tris, 25 mM, glycine, 190 mM, 0.1% SDS; methanol 20%, in a final volume of 1L-TGS 
100ml, 200 methanol, 700 distillate water), samples were transferred to a nitrocellulose 
membrane (1h at 100 volts).  
 
Nitrocellulose membranes were incubated overnight in blocking buffer (PBS, Tween 
0.1%, and BSA 3%) at 4º C with agitation. The incubation with the primary antibody 
(mAbs IgG2b anti-α-Gal; 1µg/mL in 7mL of blocking buffer) was performed in a 50 ml 
Falcon tube (overnight; 4 ºC with gentle agitation). Membranes were washed three times 
(PBS, Tween 0.1%) and 1hour incubation with secondary antibody (anti-mouse 
conjugated with Horseradish peroxidase – HRP) diluted 1:10000 in blocking buffer. After 
washing 3 times (PBS, Tween0.1%), proteins were visualized using an Immobilon 
Western Chemiluminescent HRP Substrate (WBKLS0500, Merck Millipore) in a 
ChemiDoc system.  
 
8. Sporozoite α-Gal detection by flow cytometry 
Pools of 20-30 SGs or 10-20 MGs were macerated and fixed as described above. SPZs 
were incubated overnight at 4º C with 100µL of mAb_anti-α-Gal IgG2b (50µg/mL), 
100µL anti-CSP IgG (10µg/mL) or with 50 µL Alexa Fluor® 647 conjugated BSI-B4 
(100µg/mL, Invitrogen). Samples were washed with PBS, centrifuged (Eppendorf 
Centrifuge 5417C at 9 279g for 8min), and resuspended in PBS. Samples were incubated 
with the secondary antibody (Goat Anti-Mouse IgG-H+L conjugated with Alexa Flour® 




647, Molecular Probes®) 1:1000 in PBS for one hour at RT in the dark. Samples controls 
were incubated only with the secondary antibody. SPZs were washed with PBS, 
centrifuged at 9279g for 8min and resuspended in 120 µL of PBS, and plated in 96-well 
microplates (VWR, F-bottom, transparent).  
 
Samples were run on a flow cytometer (CytoFlex, Beckman Coulter) and data acquired 
using the following gating strategy; SPZs population was isolated by GFP expression 
using the channel FITC-A and cells complexity using the side scatter (SSC-A) channel. 
For α-Gal detection (IgG2b_Sec_Alexa647 and isolectin-BSI-IB4_Alexa647), the APC-
A channel was used. All analyses were performed used the FlowJo_v10 software and 
GraphPad Prism version 6.01.   
 
9. Plasmodium berghei UDP-Gal transporter expression during 
sporogonic development 
Mosquitoes were dissected at different time points post-infection on a cold plate, 25 to 30 
SGs (14th, 16th, 18th, 23rd dpi) and 25-30 MGs (8th, 10th, 12th, 14th, 16th, 18th, 23rd dpi) were 
collected. Total RNA extraction was performed using Trizol (Bioline®) as described by 
the vendor. SG or MG pools were placed on a 1.5 mL Eppendorf tube with 100μL of 
Trisol and homogenized for 25 to 30sec using a Pellet Mixer (VWR), extra Trizol was 
added up to 1000μL. All pellet mixer tips used were previously treated with 0.01% 
diethylpyrocarbonate (DEPC, Sigma) and autoclaved to inactivate possible RNase.  
 
Tubes were shacked vigorously and incubated for 5 min at RT, 200μL of Chloroform 
(Solvay) was added and incubated for 5 min at RT. Samples were centrifuged (Eppendorf 
Centrifuge 5810R at 12000g for 5min at 4º C) and the upper aqueous phase (±500μL) 
was collected for a new tube, without touching the organic phase. 500μL of Isopropanol 
(Merck) was added and incubated for 10 min at RT and centrifuged (Eppendorf 
Centrifuge 5810R at 12000g for 10min at 4º C).  
 




Supernatants were discarded and pellets were washed with 1000μL of Ethanol 70 %, 
prepared with DEPC treated Milli Q water (Panreac), and centrifuged (Eppendorf 
Centrifuge 5810R at 7500g for 5min at 4º C). The supernatants were discarded, and pellets 
were allowed to dry for 10min at RT. Pellets were resuspended in 40μL DEPC treated 
Milli Q water and incubated at 57.5 ºC for 10 min in a heating block (thermo-block ECN: 
460-0196). Total RNA was quantified on a Nanodrop (Nanodrop 1000, 
spectrophotometer, Thermo Scientific).  
 
The cDNA synthesis was performed using a High-Capacity RNA-to-cDNA™ Kit 
(Applied Biosystems™, Thermo Fisher Scientific). Nine μL of RNA solution (0,2μg/μL), 
10μL of Buffer (that includes dNTPs, random octamers, and oligo dT-16), 1μL of enzyme 
mix (MuLV and RNase inhibitor protein), and nuclease-free water up to 20µL were added 
into 0,2ml microcentrifuge tubes. A negative control without enzyme was performed for 
each experiment. Tubes were incubated at 37º C for 60 min and a final step at 95º C for 
5 min using a thermocycler (MyCycler™ Thermal Cycler System, Bio-Rad). 
 
The exon sequence for the P. berghei UDP-GalT gene was obtained from PlasmoDB 
(https://plasmodb.org/plasmo/app/record/gene/PBANKA_0934300) with the code 
PBANKA_0934300. The online platform Primer3 (version 0.4.0; 
http://bioinfo.ut.ee/primer3-0.4.0/) was used to design specific primers (Table 2). The 
sequence of the predicted amplicon was used for a BLAST analysis on the A. stephensi 
genome (Vectorbase https://www.vectorbase.org/tool_helpers/rest/292372/results_raw) 
to detect possible unspecific amplification for mosquito’s UDP-Gal transporter gene 
(ASTE002431). A BLAST analyzes using the P. berghei genome was also performed 
(https://plasmodb.org/plasmo/showApplication.do) to ensure primers specificity. The 
BLAST results that presented more than 20 pb similar sequences with other genes and/or 
E-Value < 0.05, were discarded (Altschul; et al., 1997; Lim et al., 2016).  
 
PCR was performed using 25μL of PCR Master Mix (NZYTaq II; Nzytech), 1 μL of each 
primer (1μM final concentration), 2 μL of cDNA sample, and nuclease-free water up to 
50µL. PCR conditions are described in Table 1. Electrophoresis of PCR products was 




performed on a 1.5% w/v agarose gel, to confirm a single band amplicon of 100pb for the 
gene P. berghei UDP-GalT and of 190pb for the P. berghei ribosomal subunit 18S gene. 
The molecular weight marker HyperLadder 100bp (Bioline®) was used as the standard 
(Annex I). 
 
The expression of P. berghei ribosomal subunit 18S (Table 2) was used to normalize the 
amount of RNA expression. A serial dilution of genomic DNA from a pool of 60 infected 
SGs from A. stephensi was prepared to determine the reaction efficiency for each gene 
(18S gene = 96.7%; Pb_UDP-Gal transporter gene = 99.3%) (Annex I). At least two 
biological experiments were performed. The 2-ΔΔct method was used to quantify the fold 
change relative to Pb_UDP-GalT gene expression on  8th dpi (Lim et al., 2016; Livak & 
Schmittgen, 2001; Simões et al., 2015). 
 
10. Anopheles stephensi UDP-Gal transporter and Lectin (CTL)-
galactose-binding genes silencing 
Gene’s exon sequences were obtained from Vectorbase (ASTE002431 for UDP-GalT, 
ASTE0005494; ASTE0005491 and ASTE0001078 for lectin (CTL)-galactose-binding) 
and GeneBank (NM_009735 for mouse β-2 microglobulin_ β-2M). The online platform 
Primer3 (version 0.4.0; http://bioinfo.ut.ee/primer3-0.4.0/) was used to design specific 
primers (Table 2). A T7 phage polymerase promoter sequence 
(TAATACGACTCACTATAGGGAGA) was added to the primers to generate templates 
for the synthesis of the double-stranded RNA (dsRNA).   
 
Predicted amplicon sequences (ASTE002431_325pb; ASTE0005494_400pb; 
ASTE0005194_ 359pb; ASTE0001078_322pb; NM_009735_500pb), were used for 
BLAST analyzes against A. stephensi genome to detect possible unspecific amplification, 
using the Vectorbase BLAST tool (Vectorbase https://www.vectorbase.org/blast). 
BLAST results that presented more than 20 pb sequence homology with other genes 
and/or E-Value < 0.05, were discarded (Altschul; et al., 1997; Lim et al., 2016).  
 




PCR products were generated from DNA extract from a pool of whole A. stephensi using 
the Kit DNeasy Blood & Tissue (QIAGEN) flowing the manufacturer instructions.  PCR 
conditions were performed as described in Table 1.  PCR products were electrophoresed 
using a 1.5% agarose gel to confirm a single band amplicon of the expected size. The 
HyperLadder 100bp (Bioline®) molecular weight marker was used as a standard. Specific 
PCR products were purified using the SureClean Plus Kit (Bioline®), following the 
manufacturer's instructions (Annex II and III). Finally, the PCR products were quantified 
on nanodrop (Nanodrop 1000, spectrophotometer, Thermo Scientific).  





























































































Nº of cycles  1 35 1 α 
 
Specific double-stranded RNA (dsRNA) for A. stephensi UDP-Gal transporter and three 
lectin-galactose-binding genes were synthesized using MEGAscript™ RNAi Kit 
(Ambion™) following the manufacturer instructions. In a 1.5 mL Eppendorf tube 8 μL 
of each dNTPs (ATP, CTP, UDP concentration 75mM, and GTP concentration 15mM), 
8 μL of 10X reaction buffer, 8μL of enzyme mix (T7 RNA polymerase), and 10μL of 
PCR template (1.5-2μg) and nuclease-free water up to 80µL were added. The mix was 
incubated at 37º C for 20 hours in a heating block (thermo-block ECN: 460-0196) (Félix 
& Silveira, 2011) (Annex II and III). 
 




To clean and purify the dsRNA, 1μL of DNase (2U/μL) was added to the mixture and 
incubated at 37º C for 30 min in a heating block (Thermo-block ECN: 460-0196). The 
reaction was stopped with Ammonium acetate (15μL/115μL water, AmbionTM). Two 
hundred and ten μL of a mixture of Phenol: Chloroform: Isoamyl Alcohol 25:24:1, 
saturated with 10mM Tris, pH 8; 0,1mM EDTA (SIGMA) was added and thoroughly 
mixed and 420μL of Chloroform (Solvay) added. The aqueous phase (±175μL) was 
collected to a new tube and 175μL of isopropanol (Merck) was added. Tubes were 
incubated at -20ºC for 20 min. Tubes were centrifuged at 20817g for 15min at 4ºC, the 
supernatant was removed, and the pellet resuspended in 40μL of nuclease-free water. 
Electrophoresis using a 1.5% agarose gel was preformatted to evaluate the dsRNA quality. 
The dsRNA was quantified using a Nanodrop (Nanodrop 1000, spectrophotometer, 
Thermo Scientific). The dsRNA was stored at -20ºC until use. 




Forward (RT) 5`- AATTGAAGGTGCAAAACCAT-3` 
Reverse (RT) 5`- AAAGAATTGGCCTAAAGTTCCA-3` 
Pb_ Ribosomal 18S  
Forward (RT) 5`-GTAATTGGAATGATAGGAATTTACAAGGT -3` 
Reverse (RT) 5`-TCAACTACGAACGTTTTAACTGCAAC -3` 
ASTE_UDP_GalT  
Forward (ds) 
              (RT) 
5`-TAATACGACTCACTATAGGGAGAGTCGACGGTACACCAAAGGT-3` 
5`ATCACTCGGCCAACTGCTAC -3`   
Reverse (ds) 
             (RT) 
5`-TAATACGACTCACTATAGGGAGATTAGTCCGTCCATCGAAAGG-3` 





              (RT) 
5`-TAATACGACTCACTATAGGGAGACTTGCTGACAAACGAGTGGA-3` 
5`-GGACCTGGAACCAAAGAACA-3`   
Reverse (ds) 






Forward (ds) 5`-TAATACGACTCACTATAGGGAGACTGTGCGACTTCAAGGGATG-3` 
               (RT) 5`-ACTGTTTGGCCATCCTGAAC-3`   
Reverse (ds) 5`-TAATACGACTCACTATAGGGAGATCGGATTGCTGTACTTGACG-3` 





               (RT) 
5`-TAATACGACTCACTATAGGGAGATGTGCGACATGCGACGTA-3` 
5`-ACTTCTTCAGCTGGGAGCAT-3`   
Reverse (ds) 
              (RT) 
5`-TAATACGACTCACTATAGGGAGACTGTGCTGCTTCACGGTTGT -3` 
















Forward (RT) 5`-CGTGAGGTCGAGTTCAACAA -3`   




Forward (RT) 5`- CATTCTGCCCAAACCGATGCGT - 3` 
Reverse (RT) 5`- CATTCTGCCCAAACCGATGCGT - 3` 
AGA_UDP_GalT.  
Forward (ds) 
              (RT) 
5`- TAATACGACTCACTATAGGGAGAGTTCGTTCTGTTCGCTCTCC - 3` 
5`-ACATGATGCTGGCGATGAAC - 3` 
Reverse (ds) 
              (RT) 
5`- TAATACGACTCACTATAGGGAGATCGCCTTCACTCTTGTCCTT- 3` 
5`-GGAGAGCGAACAGAACGAAC - 3` 
*(Félix & Silveira, 2011) **(Hermsen et al., 2001) ***(Simões et al., 2015) 
 
Mosquitoes, infected with P. berghei at the 8th dpi, were cold-anesthetized (-20ºC/60sec.) 
and maintained on ice for 3-5min.  Mosquitoes were intra-thoracically injected with 69nL 
of dsRNA (3.5-4μg/μL) using a microinjection system (Nanoject II; Drummond 
Scientific) with microinjection glass needles (Capillaries, Drummond Scientific; L, 3-1/2 
in. (9cm); ID x OD 0.53 x 1.14mm/ Puller Sutter settings: Heat=560, Pull=55, Vel.=80 
Del. = 190, Model P-97 micropipette puller). For control groups, mosquitoes were 
injected with the exogenous β2M gene dsRNA (Félix & Silveira, 2011). 
 
Gene silencing was evaluated four days after dsRNA injection by quantifying the mRNA 
expression levels of the genes under study. RNA preparation and cDNA synthesis were 
performed as described above. RNA was extracted from a pool of 16-35 mosquitoes. For 
each RT-qPCR reaction 10μL of iTaqTM universal SYBR® Green supermix 2X (Bio-Rad) 
0.12μL (500nM) of each primer, 2μL of cDNA and nuclease-free water up to 20µL. Three 
replicates were prepared for each sample. Specific primers (Table 2) were designed and 
tested by BLAST analysis (see above). All reactions were prepared on ice and reactions 
were performed in a 96 x 0.2ml well Plate (BIOplastics BV) and sealed with a transparent 
adhesive tape. Specific primers for the genes under study and the mosquito ribosomal S7 
gene (Vectorbase: ASTE004816) were used (Table 2). Mosquito´s ribosomal S7 gene 
was used to normalize the amount of total RNA expression. For each gene-specific qPCR, 




programs were used (Table 3) and run on the qPCR thermocycler (Bio-Rad Hercules, CA, 
US). 
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A serial dilution of genomic DNA from a pool uninfected An. stephensi was prepared to 
determine the reaction efficiency for each gene comparatively to reference gene (S7) 
(ASTE004816_S7 gene = 100%; ASTE002431_UDP-GalT= ASTE0005494 = 107.7%; 
ASTE0005491 = 109.4%; and ASTE0001078=101.6%) using qPCR efficiency calculator, 
ThermoFisher online plataforme  
(https://www.thermofisher.com/pt/en/home/brands/thermo-scientific/molecular-
biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-
scientific-web-tools/qpcr-efficiency-calculator.html) (Bustin et al., 2009). 
 
At least three biological replicates were performed for each gene. The 2-ΔΔct Method was 
used to quantify the fold change of expression between mosquitoes treated with 
dsRNA_gene and controls tread with dsRNA_β2M. Genes were considered silenced 
when up to 2-Log fold change was observed (Bustin et al., 2009; Félix & Silveira, 2011; 
Hermsen et al., 2001; Livak & Schmittgen, 2001). 
 




11. Mosquito cells UDP-Gal transporter gene silencing. 
 A suspension of 5x105 4a3a cells in 500 µl of Schneider’s medium was transferred to a 
Chamber SlideTM (Lab-Tek® Chamber SlideTMSystem 177445, 8 well Permanox® 
Slide) and was dsRNA AGA_UDP-Gal Transp was added to a final concentration of 
100µg/µL. The AGA_UDP-Gal Transp dsRNA was prepared as described above.  For 
the control dsRNA, the β2M gene was used.  
 
Cells were incubated for 24h at 27ºC in a humidity chamber. The cell monolayer was 
fixed with 4% w/v paraformaldehyde (20-30 min, Alfa Aesar, ThermoFisher) directly on 
the slide, gently washed with PBS, and incubated overnight with 100µL mAb-anti-α-Gal 
IgG2b (50 µg/µL) or 100 µL of Alexa Fluor® 647 conjugated BSI-IB4 (100µg/mL; 
Invitrogen) at 4º C in the dark in a humidity chamber. After incubation samples were 
gently washed with PBS and 10μL of secondary antibody (Alexa Flour® 647 Goat Anti-
Mouse IgG-H+L; 10μL; 1:1000; Molecular Probes®) was added, except for those with 
BSI-IB4, followed by one-hour incubation at RT in dark. Slides were washed (PBS1X) 
and mounted with VECTASHIELD containing DAPI (Vector Laboratories, Inc.) and 
observe under the fluorescent microscope, using Cy5 and DAPI filters using 40X or 100X 
amplification. ImageJ 1.52n software (https://imagej.nih.gov/ij/) was used to marge 
channel and create composite images. 
 
For flow cytometry analyses after incubation cells were removed from the slide using a 
micro-pipet, suspended, and transferred to a 1.5mL Eppendorf. Cells were fixed with 4% 
w/v paraformaldehyde (Alfa Aesar, ThermoFisher) for 20-30 min. Cells were stained as 
described above with anti-α-Gal IgG2b mAb and BSI-IB4. After staining, cells were 
incubated with SYBR Green (Invitrogen™ ),  adapted from (Machado et al., 2016) in 
order to separated cells for debris (adapted from Machado et al., 2016). Samples were 
read on a flow cytometer (CytoFlex, Beckman Coulter) using the following gating 
strategy: Cells population were isolated using the channel FITC-A and cell complexity 
using the side scatter (SSC-A) channel. For α-Gal detection (mAb_IgG2b_Sec_Alexa647 
and isolectin-BSI-IB4_Alexa647), the APC-A channel was used. All analyses were 
performed used the FlowJo_v10 software and GraphPad Prism version 6.01. RT_qPCR 




was performed to confirm gene silencing. Was used the same protocol as described above 
for RNA extraction, cDNA production, and RT_qPCR.  
 
12. α-Gal Detection on Plasmodium berghei sporozoite gliding trails  
Mosquitoes were dissected 18–23rd dpi as described above and the SGs were placed in 
1.5mL LoBind microfuge tubes (Eppendorf) with 100μL of RPMI 1640 medium 
(Invitrogen Life Technologies), supplemented by 10% inactivated fetal bovine serum 
(FBS, Sigma). SGs were homogenized for 25-30se. using a Pellet Mixer (VWR) to release 
SPZs. The SPZs were filtered using a 35µm-mesh; Corning™ Falcon™ Test Tube with 
Cell Strainer Snap Cap. Concentration was adjusted to 1,000 SPZ/μL. Twenty μL of the 
SPZs solution was transferred to a Chamber SlideTM (Lab-Tek® Chamber SlideTMSystem 
177445, 8 well Permanox® Slide) and centrifuged for 5 min at 50g at 22°C (Carey et al., 
2013; Santos et al., 2017).  
 
Slides were carefully transferred to a cell culture incubator (37º C; 5% CO2 atmosphere) 
and SPZs were allowed to glide for 20-30 min. After that, the medium was gently 
removed from the edge of the slide wells with a pipette. SPZs were fixed with 20 μL of 
PFA 4% w/v in PBS for 30 min at RT, washed with PBS, and blocked with BSA 2% w/v 
in PBS1X for 1 hour at RT. Blocking solution was removed and samples were washed 
with PBS and 20μL of primary antibody (anti-α-Gal IgG2b; 50μg/mL or anti-CSP IgG 
10μg/mL) was added. Slides were incubated overnight at 4°C in dark in a humidity 
chamber (Carey et al., 2013; Santos et al., 2017).  
 
Primary antibodies were removed, and slides were washed with PBS. 20μL of secondary 
antibody diluted 1:1000 in PBS (Alexa Flour® 647 Goat Anti-Mouse IgG-H+L; 10μL; 
Molecular Probes®) was added and incubated for 1hour at RT in a humidity chamber in 
the dark. The secondary antibody was removed, and slides were washed with PBS. 
VectaSHIELD containing DAPI (Vector Laboratories, Inc) was used to mount the 
preparation. Slides were observed under a fluorescent microscope (Nikon, Eclipse 80i, 
CameraDS-Ri1, with software NIS-Elements BR 3.2). Slides were observed using GFP, 




Cy5, and DAPI filters with 40X or 100X magnification. ImageJ 1.52n software 
(https://imagej.nih.gov/ij/) was used to marge channels and create composite images.  
 
13. In vitro sporozoite gliding motility assays 
The SGs from infected mosquitos (18–23rd dpi) were dissected as described above. SGs 
were suspended in 100μL of RPMI 1640 medium (Invitrogen Life Technologies), 
supplemented with inactivated FBS (Sigma, 10%). SGs were homogenized for 25-30sec. 
using a Pellet Mixer (VWR), to released SPZs and filtered using a 35µm-mesh; 
Corning™ Falcon™ Test Tube with Cell Strainer Snap Cap. Immediately SPZs solution 
at 8000-11000 SPZ/μL) were incubated 1h at RT with 50µL of anti-CSP IgG (10µg/mL), 
50µL anti-α-Gal IgG2b (150 µg/µL), 10 µL Isolectin BSI-B4 (100µg/mL) or only with 
the medium for the control.  
 
After incubation 5μL of SPZ solution was pipetted onto a glass slide (diagnostic PTFE 
Slide 25x75x1mm, 3 Black Wells 14mm) and covered with a coverslip avoiding air 
bubbles and incubated for 5 min at RT. Motility was assessed by imaging SPZs using a 
fluorescent microscope (Axioskop Zeiss) with a GFP filter. Images were acquired with a 
ProgRes® C12plus camera and the ProRes® CapturePro 2.1-JENOPTIK Laser, Optik, 
Systeme GmbH software. A 20X objective was used and fifty images for each sample 
were acquired. SPZs movements were assessed using ImageJ 1.52n software 
(https://imagej.nih.gov/ij/). To classify sporozoite motility a Max Intensity image from a 
Z-projection (Maximum projections) was generated and a cell counter was used to 
quantify them. SPZs movements were clustered in three types; circular gliding, back-and-
forth gliding, and gliding with translational movement. The speed of continuous 
movement was determined using the manual tracking plug-in of ImageJ 1.52n software 
(Carey et al., 2013; Santos et al., 2017). 
 
Statistical methods: Statistical analyses were performed using GraphPad Prism version 
6.01 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com. 
Kruskal-Wallis, Mann Whitney, and Wilcoxon tests were used for group comparison with 




pValue ≥ 0.05 as significant. Linear regression was used to compare α-Gal and CSP 
detection in SPZs samples dilution.    
 




































CHAPTER III: RESULTS 
1. An. stephensi infected with P. berghei 
BALB/c mice infected with P. berghei expressing GFP in all stages of their life cycle 
(PbAEEF1αGFP), were used to fed female An. stephensi mosquitoes. Under a fluorescent 
microscope using a GFP filter, infected mosquitoes (green on abdomen and thorax region) 
were selected for each experiment (Figure 9). All non-infected mosquitoes (i.e. 
mosquitoes in which GFP was not detected) were not used. Mature oocysts were easily 
detected in mosquitoes' MGs from the 8th dpi onwards, but no SPZs were observed on the 
SGs or hemolymph (HL) this early. From the 14th dpi mosquitoes started to present SPZs 
in SGs. SPZs from both MGs and SGs were used for α-Gal, CSP, and BSI-B4 staining 
and gliding mobility assays. 
 
Figure 9: An. stephensi infected with P. berghei strain PbAEEF1a-GFP.  
A – Abdomen region of an infected mosquito 8dpi; B – Thorax region of an infected mosquito on the 16th 
dpi; Bare = 500µm.  
 
2. Detention of α-Gal on P. berghei and mosquito’s SGs/MGs 
The same mAb use to detect α-Gal glycan on Plasmodium SPZs and in mosquito’s tissues 
was tested on rat RBCs that are known to contain the α-Gal (Azimzadeh et al., 1997) 
confirming its capacity to detect the α-Gal epitope (Figure 10). 
A B





Figure 10: α-Gal detection on Rat RBCs using IgG2b anti-α-Gal mAb. 
Rat RBCs stained with IgG2B anti- α-Gal mAb and the secondary Ab anti-mouse-IgG Alexa647. Phase-
contrast microscopy and α-Gal stained red (using Cy5 filter); Negative control, rat RBCs were incubated 
just with the secondary Ab. Bar = 20µm. 
 
2.1 Mosquito´s α-Gal detection  
An. stephensi MG and SGs were stained with isolectin-BSI-IB4 and anti-α-Gal mAb 
conjugated with Alexa647 and observed under fluorescent microscopy using the Cy5 
filter (Figure 11). The Isolectin BSI-IB4 selectively binds the α-D-galactosyl residues 
including the α-Gal (Eckhardt & Goldstein, 1983; Gerke & Plenderleith, 2002; Macher 
& Galili, 2008), and the mAb-anti-α-Gal is specific for α-Gal ( Yilmaz et al., 2014). Both 
tissues were stained, showing strong evidence for the presence of α-Gal on those mosquito 
tissues.  
 
The α-Gal glycan was located at the surface of SGs cells and was more abundant in the 
apical region (Figure 11). On MG α-Gal was detected at the surface wall but not where 
the Plasmodium oocytes were located (Figure 11), suggesting that the BSI-IB4 cannot 
cross the oocyst wall. Like infected mosquitos, uninfected mosquitoes (Figure 11) also 
shown α-Gal in SGs and MG in a similar way, suggesting that α-Gal expression in 
mosquitoes SGs and MGs is independent of Plasmodium infection.   






























Figure 11: Presence of α-Gal in uninfected and P. berghei infected An. stephensi mosquito tissues 
(A) SGs and MG infected with P. berghei expressing GFP (green) expressing α-Gal detected by BSI-IB4 
conjugated with Alexa647 (red) and cell’s nucleus (blue); (B) SG and MG uninfected expressing α-Gal 
detected by BSI-IB4_Alexa647 and mAb-anti-α-Gal sec. conjugated with Alexa647 and (red) and cell’s 
nucleus (blue). For infected samples bar =20µm and uninfected samples bar =10 µm. 
 
To confirm that α-Gal was expressed in mosquito tissues, western blots were performed 
using the mAb-IgG2b anti-α-Gal on infected and uninfected SGs and MGs. In both 
infected and uninfected tissues, α-Gal was detected in association with different MW on 
the membrane (Figure 12), suggesting its association with different proteins.   
 
The western blot profiles obtained from mosquitoes SGs shown five distinct bands 
(~200KDa; ~150KDa; ~70KDa and ~30KDa (arrows)) while on MG nine bands could be 
easily detected (~100KDa; ~80KDa; ~50KDa; ~37KDa; ~30KDa; ~20KDa; ~17KDa; 
~15KDa; ~12KDa (arrows). The α-Gal seems to be present in more proteins from MGs, 
special in those with lower molecular weights (Figure 12). Most of SGs protein bands 

























































are ornamented with α-Gal is present on both organs. Non-clear differences were 
observed from infected and uninfected samples (i.e. mosquitoes SGs and MGs).  
 
Figure 12: Western blot of An. stephensi SGs and MGs for α-Gal detection using the anti-α-Gal-IgG2b-
mAb. 
SGs+Pb - SGs from P. berghei infected mosquitoes; SGs - SG from uninfected mosquitoes; MG+Pb - MGs 
from P. berghei infected mosquitoes; and MG - MGs from uninfected mosquitoes; Ladder – protein 
standard (kD). 
 
2.2 α-Gal detection on Plasmodium parasite 
Inside the midgut lumen, Plasmodium gametocytes fuse to form ookinetes, and the 
process of mosquito´s midgut invasion start (Angrisano et al., 2012; Patra & Vinetz, 2012; 
Warburg et al., 2007). Ookinetes from in vitro culture, with no previous contact with 
mosquito´s tissues, were stained using BSI-IB4-Alexa647 or with anti-α-Gal mAb and the 
secondary mAb-conjugated with Alexa647, revealing that α-Gal is expressed at this 
parasite stage. The glycan was present at the surface, but some ookinetes showed a strong 
α-Gal signal at the apical end, especially when the anti-α-Gal-mAb was used (Figure 13).   













Figure 13: α-Gal detection on Plasmodium berghei ookinetes. 
P. berghei ANKA ookinetes phase-contrast microscopy; Ookinetes expressing GFP (green); or α-Gal (red). 
Nuclei were stained with DAPI (blue). Bar = 10µm.  
 
After ookinetes successfully cross the MG epithelium, the next stage of the Plasmodium 
life cycle inside the mosquito is the oocyst formation (Angrisano et al., 2012; Clayton et 
al., 2014). When anti-α-Gal-IgG2b-mAb was used to stain oocysts in the mosquitoes` 
midgut, α-Gal was only detected surrounding oocysts (Figure 14). Using the conventional 
florescent microscopy α-Gal could not be observed inside oocysts and this could indicate 
that the α-Gal detected comes from mosquitoes' tissues surrounding the oocysts.   
 
Figure 14: α-Gal detection on P. berghei oocysts 
Oocysts expressing GFP (green) and DNA stained with DAPI (blue).; α-Gal detection on oocysts stained 
with mAb-anti-α-Gal with secondary Ab, IgG conjugated with Alexa647 (red), and DNA stained with DAPI 
(blue). Midguts were collected at 8 dpi. Bar = 20µm  
 
Plasmodium SPZs stage is critical for mosquito's SGs invasion and transmission to the 
mammalian host thus, guaranteeing the lifecycle completion (Angrisano et al., 2012; 
Orfano et al., 2016). Staining SPZs with BSI-IB4 or anti-α-Gal-mAb showed that α-Gal 
is present at their surface. The presence of α-Gal on the SPZs membrane could indicate 
that this glycan may play a role in sporozoites tissues invasion. SPZs were stained for 





























CSP using a mAb-anti-CSP with a secondary anti-mouse IgG conjugated with Alexa647, 
too (Figure 15).  
 
Figure 15: α-Gal detection on P. berghei sporozoite. 
P. berghei SPZs phase-contrast microscopy; P. berghei SPZs expressing GFP (green); SPZs stained with 
mAb-anti-CSP and a secondary Ab conjugated with Alexa647(red); SPZs stained with mAb-anti-α-Gal and 
secondary Ab conjugated with Alexa647 (red). SPZ stained with BSI-IB4 Alexa647 (red); Unstained SPZ. 
Nuclei were stained with DAPI (blue). Bar = 10µm 
 
3. Plasmodium SPZs population detection and differentiation using flow 
cytometry 
Flow cytometry is a useful tool to identify, quantify, and differentiate cells (Alvarez et 
al., 2010). Using P. berghei expressing GFP, we were able to establish a gating strategy 
that allowed the identification and differentiation of Plasmodium SPZs populations from 
mosquitoes’ MGs, hemolymph (HL), and SGs. Based on the GFP expression, the SPZ 
population (the smaller population, highlighted on the dot plot), differs from the rest of 
the events (the bigger population on the dot plot, that corresponds to mosquitoes debris) 
(Figure 16). 
 






































Figure 16: Detection of P. berghei SPZs from different mosquito tissues using flow cytometry. 
SPZs were isolated from MGs, HLs, and SGs debris based on the GFP expression by parasites.  
 
SPZs were stained with anti-CSP-mAb (secondary mAb conjugated Alexa647) and the 
identified population was highly matched with the GFP+ subset population, confirming 
that GFP isolated population corresponded truly to SPZs population (Alvarez et al., 2010; 
Kaushansky et al., 2012) (Figure 16). 
 
Figure 17: P. berghei SPZs detection using GFP and CSP expression. 
A representative of a two-parameter dot plot of SPZs expressing GFP from infected SGs. Histogram from 
SPZs, GFP gate unstained (CSP-, blue) and stained (CSP+, gray) with anti-CSP mAb and sec. Alexa647. 
 
Dot plot of SPZs from MGs Dot plot of SPZs from SGs Dot plot of SPZs from HLs
Dot plot of SPZs gate
Dot plot of GFP and CSP marge SPZs_CSP staining 
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To assure that the amount of SPZs in the sample wouldn´t influence detection, a serial 
dilution of SPZs (from SGs and MGs) was stained with mAb-anti-CSP (sec-mAb-
Alexa647) and the average intensity of CSP detection was recorded. Using a linear 
correlation, we did not observe a correlation between the amount of SPZs and the GFP or 
CSP fluorescence intensity detection, or even with the percentage of SPZs expressing 
CSP. That gives us strong evidence of independence between SPZs quantity and CSP or 
GFP detection (Figure 18).  
 
Figure 18: Serial dilution of sporozoite detection using flow cytometry. 
Quantification of SG and MG SPZs serial dilution and correlation between GFP intensity and quantity and 
SPZs number; Correlation between CSP intensity and quantity and SPZs number. The experiment was 
performed in triplicate and linear regression was performed to establish the correlations. R2≠0 is it possible 
to establish a correlation.  
 
4. Detection and quantification α-Gal on Plasmodium berghei during 
the sporogonic cycle 
With the SPZs population isolated on flow cytometry, by GFP gate (Figure 16), was 
possible to analyze the presence of SPZs expressing α-Gal using BSI-IB4 or anti-α-Gal-
mAb labeled with Alexa 647 (Figure 19). Unstained SPZs were used to define the 
threshold for negative and positive α-Gal SPZs population. This approach was used to 
determine the dynamic of α-Gal expression during the sporogonic cycle.  
 




When we look for the entire flow cytometry populations (i.e. mosquitos’ debris and SPZs) 
it´s possible to observe general α-Gal staining (Figure 19) in accordance to fluorescent 
microscopy results, where the presence of α-Gal was observed both in mosquitos tissues 
and SPZs (Figure 11 and Figure 15). 
 
Figure 19: Detection of α-Gal on P. berghei SPZs expressing GFP using flow cytometry. 
Representative two-parameter dot plot of SPZs expressing GFP and histograms from unstained samples 
(gray) and α-Gal+ (blue) stained with the anti-α-Gal-mAb or BSI-IB4 /Alexa647 (blue). Representative 
dot plot of SPZs from MGs, SGs, and HLs. 
 
The α-Gal was present in the majority of SPZs from the different mosquitos` tissues when 
both BSI-B4 Isolectin and the anti-α-Gal-mAb were used. The percentage of SPZs 
expressing α-Gal was higher in SPZs from SGs when compared with SPZs from MGs or 
HLs (Figure 20). It’s interesting to note that the percentage of SPZs expressing α-Gal was 
Dot plot of SPZs gate
SPZs population subset staining 
with mAb-anti-α-Gal  
SPZs population subset staining 
with BSI-B4 Isolectin
SPZs population subset expressing α-Gal
SPZs_α-Gal- SPZs_α-Gal+
SPZs_α-Gal- SPZs_α-Gal+




higher in SPZs who had invaded SGs suggesting some associated with maturation and/or 
salivary glands invasion process.   
 
Figure 20: Expression of α-Gal on sporozoites from different mosquito tissues. 
A – SPZ stained with anti-α-Gal mAb. Groups were compared using the Kruskal-Wallis test with a 
significant difference pValue ≥0.05. MG-midgut, HL-hemolymph, SG-salivary glands. 
 
To address if the amount of α-Gal on SPZs changed along the sporogonic cycle the 
intensity of the α-Gal signal was compared between SPZs from the different organs using 
mAb-anti-α-Gal and Isolectin BSI-B4. No significant differences were observed between 
tissues using both approaches (Figure 21).  
 
Figure 21: Intensity of α-Gal expression on sporozoites from different mosquito tissues. 
A –SPZs stained with anti-α-Gal-mAb. Groups were compared using Kruskal-Wallis test with significant 
difference pValue ≥0.05. MG-midgut, HL-hemolymph, SG-salivary glands, SPZ-sporozoites. 
 
In the attempt to characterize the dynamic of α-Gal expression during SPZs development, 
SPZs from MGs, HL, and SGs were collected and stained for α-Gal at different days post-
infection (8th, 10th, 12th, 14th, 16th, 18th, and 23rd). Using the flow cytometry approach to 
access SPZs α-Gal expression, results show variations between biological replicate, but 
non-statistical differences were observed between time-points regardless of the tissue 
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origin of SPZs. From the 14th dpi onwards the number of SPZs expressing α-Gal tended 
to decrease when the anti-α-Gal-mAb was used, but the same effect was not observed on 
BSI-B4 Isolectin (Figure 22). 
 
Figure 22: Percentage of P. berghei SPZs expressing α-Gal form An. stephensi MG in different days post 
infection. 
A –SPZs stained with anti-α-Gal-mAb. B SPZs stained with BSI-B4 Isolectin. Groups were compared using 
the Kruskal-Wallis test. Differences were considered significant for pValue <0.05.  
 
Analyzing the amount of α-Gal expressed (i.e. flow cytometry signal intensity, filter 
APC) on SPZs from MGs in different days post-infection, no significant differences were 
observed (Figure 23). No correlation could be established between the amount of α-Gal 
on MG SPZs and time.  
Figure 23: Intensity of α-Gal expression on P. berghei SPZs form An. stephensi MG at different days 
post-infection. 
A – SPZs stained with mAb-IgG2b-anti-α-Gal.  B – SPZs stained with BSI-B4 Isolectin. Groups were 
compared using the Kruskal-Wallis test. Differences were considered significant for pValue <0.05  
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SPZs from mosquito’s HL and SGs were also analyzed for the presence of α-Gal from 
the 14th to 23rd dpi, and like in MGs samples, no statistical differences were observed on 
those expressions from SGs and HL samples (Figure 24). 
Figure 24: Percentage of P. berghei SPZs expressing α-Gal form different An. stephensi tissues at 
different days post-infection. 
A- SPZ from the Hemolymph s expressing α-Gal detected with anti-α-Gal-mAb. B - SPZ from the 
Hemolymph expressing α-Gal detected with BSI-B4 Isolectin; C - SPZ from the salivary glands expressing 
α-Gal detected by anti-α-Gal-mAb. D - SPZ from the salivary gland expressing α-Gal detected with BSI-
B4 Isolectin. Groups were compared using the Kruskal-Wallis test. Differences were considered significant 
for pValue <0.05 
 
The amount of α-Gal on SPZs from SGs and HL were accessed by the fluorescence 
intensity using the APC filter on the flow cytometer. The median of this florescent 
intensity was used to compare the α-Gal expression on SPZs from different days post-
infection (14th to 23rd dpi). One more time, no statistical differences were observed with 
the exception when SGs samples from 14th with 23rd dpi were compared using mAb-
IgGb-anti-α-Gal (p=0.0142) (Figure 25).  
 





Figure 25: α-Gal expression on P. berghei SPZs from different An. stephensi tissues at different days 
post-infection. 
A- SPZs from hemolymph s detected with anti-α-Gal-mAb. B - SPZs from hemolymph SPZs detected with 
BSI-B4 Isolectin; C - SPZs from salivary glands SPZs detected with anti-α-Gal-mAb. D - SPZs from 
salivary gland SPZs detected with BSI-B4 Isolectin - Groups were compared using the Kruskal-Wallis test.  
 
5.  Detection and quantification of Plasmodium berghei UDP-Gal-
Transporter gene expression in SPZs from MGs and SGs. 
The UDP-Gal and the UDP-GalNAc are nucleotide sugar transported by UDP-Gal-
Transporter (UDP-GalT), a protein with an important role in galactose (Gal) structures 
formation including the α-Gal epitope (Cova et al., 2015; Segawa et al., 2002). Given the 
fact that none specific gene from α1,3GalT in Plasmodium was already detected (Cova et 
al., 2015; Yilmaz et al., 2014), explore downstairs steps in the α-Gal epitope pathway 
could give us an idea of its expression.  To understand the dynamic of UDP-GalT 
expression in SPZs from the MGs and the SGs in different days post post-infection, RT-
qPCR was performed to quantify the expression of this gene in samples from different 
time points. 




The results show variations in the UDP-GalT gene expression on SPZs from MGs. The 
highest expression was observed on SPZs on the 18th dpi when compared with the other 
time points and the expression at day 23rd dpi was the lowest (Figure 26 blue line). For 
SPZs from SGs, three time points (14th, 16th, and 18th dpi) were analyzed and, the UDP-
GalT gene expression increased from the 14th to the 18th dpi (Figure 26 red line).  
 
Figure 26: P. berghei UDP-GalT expression from SPZs from MGs and SGs of An. stephensi at different 
days post-infection. 
The P. berghei 18S rRNA gene expression was used to normalize the total amount of RNA. All-time 
points were compared to 8dpi using the 2-ΔΔCT method. The results represent two-three biological 
replicates. 
 
6. An. stephensi UDP-Gal transporter gene silencing. 
As shown in a previous study (Yilmaz et al., 2014) and above (Figure 11 and Figure 12), 
α-Gal is present in mosquito tissues. However, so far, no homologous mosquito gene for 
α1,3GalT enzyme has yet been identified. Therefore, targeting the UDP-Gal transport 
seems to be a good approach to disrupt the α-Gal presence in mosquito tissues to test if 
Plasmodium α-Gal present or not a mosquito origin.    
 




6.1 UDP-Gal transport silencing and α-Gal production by a mosquito cell 
line. 
The presence of α-Gal in Anopheles mosquito cell line 4a3a was confirmed, using anti-α-
Gal-mAb and BSI-IB4 Isolectin (Figure 27). Using the same approach in other to different 
mosquito line cells (4a3b and SAU51), the α-Gal epitope was detected too (Annex V).  
 
Figure 27: α-Gal detection on 4a3a mosquito’s cell line. 
Cells 4a3a phase-contrast microscopy image; Cells 4a3a stained with anti-α-Gal-mAb and secondary mAb 
conjugated with Alexa647 (red). Cells 4a3a stained with BSI-IB4 conjugated with Alexa647 (red); 
Unstaining Cells 4a3a. Nuclei were stained with DAPI (blue); Bar = 50µm.  
  
The Anopheles mosquito cell line, 4a3a, was in vitro cultivated and the UDP-GalT gene 
was silenced using specific dsRNA. After 24h incubation with dsRNA, α-Gal was 
detected in the cells using anti-α-Gal-mAb and the BSI-IB4 Isolectin. The fold change 
was calculated using the 2-ΔΔct method and an average of 3.2-fold Log2 change was 
detected, in the UDP-GalT gene expression when specific dsRNA was used. The 
reduction of α-Gal expression could be visualized under the fluorescent microscope when 
cells were stained with the anti-α-Gal-mAb but are not so clear when the BSI-IB4 Isolectin 
was used (Figure 28). This direct measure of α-Gal after UDP-GalT silence could be a 










































Figure 28: The effect of UDP-GalT gene silencing on α-Gal expression in 4a3a mosquito’s cell line. 
α-Gal detected by anti-α-Gal-mAb (sec.Alexa647) (red) in cells incubate with dsRNA β2M gene (control); 
α-Gal detected by anti-α-Gal-mAb in cells incubate with dsRNA form UDP-Gal transporter gene; α-Gal 
detected by BSI-IB4 Isolectin_Alexa647 (red) in cells incubate with dsRNA β2M gene (control); α-Gal 
detected by BSI-IB4 Isolectin_Alexa647  (red) in cells incubated with dsRNA form UDP-Gal transporter 
gene; Unstained cells; Contrast phase microscopy image form cells incubate with dsRNA form UDP-Gal 
transporter gene or β2M gene; DAPI using to staining nucleus (blue). Bar = 50µm.   
 
To confirm the effect of UDP-GalT silencing, cells were analyzed for the presence of α-
Gal using a flow cytometry approach. The median of florescent associate with α-Gal 
detection using the anti-α-Gal-mAb and BSI-IB4 Isolectin were compared between cells 
silenced for UDP-GalT and controls (dsRNA_β2M). A reduction of more than 50%, was 
detected when silenced cells were compared with the negative control or untreated cells 
(Figure 29). 
 










































































































Figure 29: Detection and quantification of α-Gal by flow cytometry on 4a3a cell line treated with dsRNA 
targeting the UDP-GalT gene and dsRNA targeting the mouse β2M as the negative control. 
Groups were compared using the Wilcoxon matched-pairs signed-rank test with a significant difference 
pValue ≥ 0.05. Results represent three biological replicates.  
 
7. Mosquito UDP-Gal transporter silencing and α-Gal expression on 
parasite SPZs 
 
RT-qPCR was used to assess the amount of mRNA after treatment with dsRNA for the 
target gene or the control. The fold change was calculated using the 2-ΔΔct method. An 
average of 8-fold log2 change was detected (Figure 30).  
 
Figure 30: Mosquito`s UDP-GalT down-regulated using dsRNA_UDP-GalT.  
 
A reduction in the percentage of SPZs from MGs expressing α-Gal (detected with anti-α-











α-Gal expression detected 
with mAb-IgG2b-anti-α-Gal 
α-Gal expression detected 

























































































the control. In parallel, the fluorescence intensity was also decreased on the SPZ from the 
MG (Figure 31), but no differences in expression were observed using SPZs from SGs. 
When the BSI-IB4-isolectin was used to detect α-Gal on SPZs (SGs and MGs) in the same 
way no-difference were detected between those from treated mosquitoes (dsRNA_UDP-
GalT) and the control (dsRNA_β2M).  
 
Figure 31: Effect of mosquito UDP-GalT silencing on the expression of α-Gal on sporozoites from An. 
Stephensi SGs. 
A and B-Percentage of SGs sporozoites expressing α-Gal collected from An. stephensi, injected with 
dsRNA_UDP-GalT gene and dsRNA_β2M stained with anti-α-Gal-mAb (A) and with Isolectin-BSI-B4 
(B); C and D – Median intensity detected by flow cytometry on SPZs from SGs from An. stephensi injected 
with dsRNA UDP-GalT gene and dsRNA β2M gene detected by anti-α-Gal-mAb (A) and with Isolectin 
BSI-B4 (B). Groups were compared using the Mann Whitney test with a significant difference P-value ≥ 











































































































































































Figure 32: Effect of mosquito UDP-GalT silencing on the expression of α-Gal on SPZs from An. 
stephensi MGs.  
A and B-Percentage SPZs from MGs expression α-Gal collected from An. stephensi, injected with 
dsRNA_UDP-GalT gene and dsRNA_β2M stained with anti-α-Gal-mAb and with Isolectin-BSI-B4 
respectively. Groups were compared using the Mann-Whitney test with a significant difference P value ≥ 
0.05. C and D – Median intensity detected by flow cytometry on SPZs from An. stephensi MGs injected 
with dsRNA UDP-GalT gene and dsRNA β2M gene detected by anti-α-Gal-mAb and Isolectin-BSI-B4 
respectively. Groups were compared using the Wilcoxon matched-pairs signed-rank test with a significant 
difference P-Value ≥ 0.05. Results represent three biological replicates. The number of mosquitos NdsUDP-
GalT =138 Ndsβ2M =117.  
 
8. α-Gal and Plasmodium SGs invasion 
8.1 The role of α-Gal in SPZs invasion of SGs – An. stephensi UDP-GalT 
gene silencing  
 
To understate if mosquitoes’ α-Gal plays a role in the process of SGs invasion by 
Plasmodium SPZs, the number of SPZs from mosquitoes that have been silenced for 
UDP-GalT gene was compared with SPZs number from the control group. The number 































































































































































differences when compared with the control group. However, the number of SPZs in SGs 
present a significant reduction when the mosquito’s UDP-GalT gene was silenced (Figure 
33). The results suggest that mosquitoes’ UDP-GalT is not involved in the maturation 
process of SPZs inside oocytes but affect the Plasmodium SGs invasion.  
 
Figure 33: Effect of A. stephensi UDP-GalT silencing on the amount of Plasmodium SPZs in MGs and 
SGs. 
The number of sporozoites was normalized 100% for the negative control ds_β2M. Groups were compared 
using the Wilcoxon matched-pairs signed-rank test with a significant difference P-Value ≥ 0.05. Results 
represent three biological replicates. Number of mosquitos used; NdsUDP-GalT =138 Ndsβ2M =117.  
 
8.2 The role of α-Gal in sporozoite invasion of salivary glands: An. 
stephensi lectin binding-Gal gene (CTL) silencing  
 
Lectins are carbohydrate-binding proteins with distinct sugar specificities. In mosquitoes, 
these molecules play an important role in immune defense and the parasite protozoans 
interaction (Changlin Chen & Billingsley, 1999; Ratcliffe et al., 1985). Three lectins able 
to bind Galactose are annotated at the An. stephensi genome: ASTE0005494, 
ASTE0001078 and ASTE0005194.  
 
To understand their role in SPZ invasion of SG, genes that transcribed these lectins were 
silenced using specific dsRNA. The fold change was calculated using the 2-ΔΔct method 
to calculate the silence rate. Even if the standard methodology for gene silencing in 
mosquitoes based on specific dsRNA microinjection was used only the gene 

























































(Figure 34_A), while for ASTE0001078 and ASTE0005194 gene expression was either 
not affected or was increased (ASTE0005194) (Figure 34). 
 
Figure 34: Effect of mosquito`s CTLs gene expression after treatment with dsRNA_CTL. 
 
When ASTE005494 was silenced a significant reduction of Plasmodium SPZs in the MG 
and SG was observed. For the other two genes (ASTE0001078 and ASTE0005194) tested 
it was not possible to silence their expression and no differences were observed in the 
SPZs number, both from SG or MGs. The α-Gal in SPZs may be recognized by this lectin 
that binds galactose (Gal), suggesting an indirect link between α-Gal (or another Gal 
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Figure 35: Effect of A. stephensi C type Lectin gene silencing on Plasmodium SPZs in salivary glands 
and midguts. 
 A – SPZs from Salivary Glands; B – SPZs from Midguts. The number of SPZs were normalized 100% for 
the negative control ds_β2M. Groups were compared using the Wilcoxon matched-pairs signed-rank test 
with a significant difference P-Value ≥ 0.05. Results represent three biological replicates. The number of 
mosquitos injected with; NdsCTL=96 Ndsβ2M =128. 
 
SPZs isolated from mosquitoes silenced for the ASTE0005494 gene were tested for the 
presence of α-Gal by flow cytometry. SG SPZs from ASTE0005494 silenced mosquitoes 
had an increased amount of α-Gal (Figure 36) when detection was performed using anti- 
α-Gal-mAb. However, when BSI-IB4 Isolectin has used no differences were observed 











































































Figure 36: Detection and quantification of α-Gal on SPZs from SG of An. stephensi mosquitoes silenced 
for the Gal-binding lectin gene (ASTE005494). 
A and B-Percentage of SGs sporozoites expressing α-Gal collected from An. stephensi, injected with 
dsRNA_ ASTE005494 gene or dsRNA_β2M stained with anti-α-Gal-mAb and with Isolectin-BSI-B4 
respectively. Groups were compared using the Mann-Whitney test with significant differences for P-value 






























































































































































Figure 37: Detection and quantification of α-Gal on SPZs from MG of An. stephensi mosquitoes injected 
with dsRNA for the mosquito´s Gal-binding lectin gene (ASTE005494). 
A and B-Percentage of MG sporozoites expression α-Gal collected from An. stephensi, injected with 
dsRNA_ ASTE005494 gene and dsRNA_β2M stained with anti-α-Gal-mAb or with Isolectin-BSI-B4 
respectively; Groups were compared using the Mann-Whitney test with a significant difference for P-value 
< 0.05. Results represent three biological replicates. The number of mosquitos injected with NdsCTL = 96 
Ndsβ2M =128. 
 
8.3 The role of α-Gal on sporozoites gliding motility  
While moving by gliding motility SPZ leaves a trail of parasite molecules that can be 
detected by immunofluorescent microscopy (Frischknecht and Matuschewski 2017). The 
presence of α-Gal on the trail was investigated. The presence of CSP on the trail was used 
as a control for SPZs gliding. Using this approach, it was not possible to detected α-Gal 
on the trail left by the SPZs gliding movements. When anti-CSP mAb was used trail 
































































































































































Figure 38: α-Gal and CSP trail detection from sporozoites isolated from An. stephensi SGs. 
Phase-contrast microscopy image of sporozoites; SPZs expressing GFP; CSP trail from SPZs detected 
with anti-CSP mAb (red); Sporozoites stained with anti-α-Gal-mAb (sec-Alexa647) (red). Nuclei stained 
with DAPI (blue). The bar scale corresponded to 10μm. 
 
8.4  The influence of mAb-anti-α-Gal and BSI-IB4_Isolectin treatment on 
SPZs gliding motility 
Image live experiments were performed to test if blocking parasite α-Gal with mAb-anti-
α-Gal or BSI-IB4_Isolectin would disturb SPZs gliding movements, an essential process 
for SGs invasion. With mAb-anti-α-Gal, no significant differences were observed 
between SPZs speed or type of movement on treated and non-treated sporozoites. 
However, using BSI-IB4_Isolectin a slit decrease in speed and the circular type gliding 
was observed when compared with the control (Figure 39). When SPZ were incubated 
with mAb-anti-CSP an almost complete blocking of SPZs movement was observed and 
those SPZ that remain moving had a dramatic reduction of speed (Figure 39). Our results 
suggest that Plasmodium α-Gal does not have a role in sporozoites' gliding mobility.  
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Figure 39: SPZs motility in the presence of anti-α-Gal-mAb, BSI-IB4_Isolectin, and anti-CSP-mAb. 
A-Maximum projections of representative SPZs without movement. B-Maximum projections of a 
representative subset SPZs with a translational movement. C-Maximum projections of a representative 
subset SPZs with back-and-forth gliding. D-Maximum projections of a representative subset SPZs with 
continuous circular gliding. E-Percentage of gliding types for different treatment. F- SPZs continue circular 
gliding relative speed for each treatment. Results are representative of three biological replicates. Results 


















CHAPTER VI: DISCUSSION 
1. α-Gal detection on Plasmodium and mosquito´s SGs and MGs 
1.1 Detection of α-Gal in different Plasmodium stages during the sporogonic 
cycle  
The study of glycans on parasites is very important to understand the process of host-
parasite interaction (Frevert, 1994; Hokke & van Diepen, 2017; Veríssimo et al., 2019; 
Zhang et al., 2013). Many glycan structures found on Plasmodium surface play important 
roles in host interaction, either in mosquito or mammalian host (Basseri et al., 2016; Cova 
et al., 2015; Gomes et al., 2017; Rodriguez & Hernández-Hernández, 2004). In our work, 
we proposed to dissect the role of the glycan α-Gal on Plasmodium interaction with 
mosquito host, especially on the process of salivary glands invasion. For that, we used 
the murine malaria model, P. berghei / An. stephensi.   
 
Using immunofluorescence the α-Gal glycan epitope was detected in all Plasmodium 
mosquitos’ stages, including ookinetes, oocyst, and sporozoites (Figure 13, Figure 14, 
and Figure 15). A previous study using a similar approach showed similar results ( Yilmaz 
et al., 2014) detecting the presence α-Gal on the surface of SPZs but our result the major 
concentration of α-Gal on the apical zone was not constant on all SPZ. The α-Gal epitope 
is not exclusive of Plasmodium and has already been detected in other protozoan parasites 
like Trypanosoma cruzi (Portillo et al., 2019) and Leishmania major (Iniguez et al., 2017).  
 
For the first time, the presence of α-Gal glycan on the surface of Plasmodium ookinetes 
and sporozoites from oocysts and hemolymph was demonstrated. As with SPZ, the α-Gal 
seems to concentrate at the ookinetes apical zone (Figure 13), which could indicate the 
role of this epitope during the peritrophic matrix and midgut epithelium penetration.  
 
It’s interesting to note that, the α-Gal detected on the oocyst is limited to the surface 
(Figure 14) which, suggests that the mAb-anti-α-Gal or BSI-IB4_Isolectin were not able 
to pass by the oocyst capsule. The Plasmodium oocyst capsule protein (PbCap380) 




located on the external surface of the oocyst, have an essential role in protecting against 
mosquitoes’ immune system being a part of the protective capsule (Prakash et al., 2008), 
and my be α-Gal can have a similar role when present on oocyst surface.  
 
This idea of oocyst capsule works as a barrier for mAb-anti-α-Gal or BSI-IB4_Isolectin 
is reinforced when SPZs from the midgut, released from oocysts, were perfectly stained 
using the same antibody and lectin (Figure 15). Also, oocysts present a capsule that 
consists of a thick outer layer formed mainly of mosquito laminin and an inner oocysts 
plasma membrane (Aly et al., 2009), further this structure could work as a barrier, not 
allowing mAb-anti-α-Gal or BSI-IB4_Isolectin to stain the oocysts inner structures. On 
other hand, we can hypothesize that α-Gal could only be expressed once SPZs are release 
from the oocyst after egress and being located in oocyst cytoplasm like CSP (Prakash et 
al., 2008; Q. Wang et al., 2005).   
 
After α-Gal detection on SPZs surface, we attempt to quantify this glycan during its 
development in the oocyst and the hemolymph and salivary glands using flow cytometry 
(Figure 25, Figure 16, and Figure 19). Previous studies, using the same approach to 
characterize and quantify SPZs (Franke-Fayard et al., 2004; Kaushansky et al., 2012; 
Yilmaz et al., 2014; Talman et al., 2010) have been used, but so far, our results seem to 
be, the only one that analyses sporozoites samples from MGs and HLs from early 8 dpi 
to 23 dpi.  
 
Percentages of SPZs, from SGs and HLs, expressing α-Gal were higher when compared 
with those from MGs, using either anti-α-Gal-mAb or BSI-IB4_Isolectin (Figure 20), 
suggesting that this glycan is produced by the SPZ through sporozoites development and 
maturation until reaching SG ducts.  
 
Different time points during infection (8dpi to 23 dpi) were used to obtain SPZs from 
different mosquito tissues (MGs, HLs, and SGs) to quantify α-Gal. A correlation between 
days post-infection and the amount of α-Gal could not be detected, but a very consistent 




decrease in the α-Gal expression on 14th dpi could be observed in all experiments when 
α-Gal was detected with anti-α-Gal mAb (Figure 22, Figure 23, and Figure 24). The 
expression of α-Gal glycan does not significantly change during the sporogonic cycle 
suggesting a constant production during the SPZs development process.  
 
The variation between experiments was observed when α-Gal was detected by flow 
cytometry, which can be explained because the process to form α-Gal epitope is extremely 
dependent on sugar subtract concentration (Takayama et al., 1999). The O-GlcNAc, one 
of the glycan present on α-Gal epitope, is dependent on cellular glucose concentration 
and this glycosylation process plays an important role in nutrition and response to 
starvation (Walski et al., 2017). Despite our results and previous ( Yilmaz et al., 2014), 
so far no evidence for an α-1,3-GalT gene in the Plasmodium genome has been found, 
suggesting that α-Gal present in different stages of Plasmodium parasite could be formed 
using different pathways (Cova et al., 2015).  
 
1.2 α-Gal detection on mosquitoes, SG, MG, and cells 
Using different approaches (i.e. immunofluorescent, western blot, and flow cytometry) 
we were able to detect the α-Gal glycan on Anopheles sp. mosquitos’ tissues (i.e. SGs and 
MGs) (Figure 11 and Figure 12) and cells (Figure 27 and Figure 29). Different lectins 
(sugar motif specific) have the capacity of biding to different Anopheles mosquitoes 
glycoproteins with different molecular weights (Wilkins & Billingsley, 2010), suggesting 
that different proteins are glycosylated with the same sugar motifs. Similarly, our western 
blot results show that different proteins were labeled with anti-α-Gal-mAb. Samples from 
different tissues of infected and uninfected mosquitoes show no clear differences in their 
western blot profile, in contradiction with previous results from (Yilmaz et al., 2014), 
which might be related to the relative amount of SPZs subtract to the host mosquito and 
the technique sensitivity.  
 
The terminal GlcNAc, fundamental for α-Gal epitope formation, is present in mosquitos 
midgut microvillar glycoproteins N-linked type (Wilkins & Billingsley, 2001), and 




studies performed with silkworm larvae show that the Gal terminal residues liked N-
glycan its always linked to GlcNAc residue (Dojima et al., 2009), reinforcing the idea 
that α-Gal epitope is present on insects special mosquitoes. Indeed, α-Gal has already 
been detected in ticks (Araujo et al., 2016; Cabezas-Cruz et al., 2018; Hamsten et al., 
2013) and our results, using both BS-BI4_Isolectin and anti-α-Gal-mAb clearly show its 
presence in mosquitos SGs, MGs (Figure 11 and Figure 12) and hemocyte-like mosquito 
cell line (Figure 27). 
 
A previous study shows that GlcNAc and GalNAc were important for ookinetes journey 
into mosquitoes midgut (Wilkins & Billingsley, 2010). So far, no study has been 
performed that demonstrates the role of α-Gal on MGs ookinete invasion, and the fact 
that an important part of the α-Gal epitope (i.e. GlcNAc residue) has been implicated in 
this process could indicate a possible contribution to the ookinete invasion process. 
 
An early study using different lectins (Con A, SBA, HPL, LFA, RCA I, SBA, UEA I, and 
WGA), that target very different polysaccharides, including the α/βGal (RCA I and SBA) 
in Aedes aegypty and An. stephensi, shows that the large majority of lectin-target 
structures were present in the microvilli of midgut epithelium and peritrophic membrane 
but not in intracellular space except Con A (Rudin; & Hecker, 1989). Between midgut 
cells are found junctional complexes that act as a mechanical linkage and connect each 
cell at their lateral borders (Whitten, Shiao, and Levashina, 2006) forming a mesh where 
α-Gal seems to be more concentrated (Figure 11). The oocyst development occurs in the 
extracellular space between the basal lamina and mosquito´s midgut epithelium (Vlachou 
et al., 2006) where α-Gal was detected.  
 
A study that used BSI-B4 lectin in insect cell lines Sf-9 (from Spodoptera frugiperda) 
and Tn (from Trichoplusia ni ) revealed the presence of Galα1-3/4Gal in those insects 
cells (Lopez et al., 1998). In the same way, and using An. gambiae 4a3a cells line, we 
were able to detect α-Gal epitope on these cells using both BSI-B4 isolectin and anti-α-
Gal-mAb (Figure 27).  




The α-Gal epitope was also detected on mosquito SGs (Figure 11 Figure 12), with a less 
intense signal when compared with MGs. Curiously, in an early study, Bandeiraea 
simplicifolia lectin I (BSL I) and Bandeiraea simplicifolia lectin II (BSL II) were not able 
to bind to salivary glands of Ae. aegypti suggesting that the absence of α-Gal epitope on 
those mosquitoes (Barreau et al., 1995).  
 
2. UDP-GalT gene involved in mosquito α-Gal production  
The α-1,3-GalT enzyme is important for α-Gal epitope synthesis, catalyzing a galactose 
(Gal) transference from UDP-Gal donor to a GlcNAc residue (Blanken & Van Den 
Eijnden, 1985; Boix et al., 2002; Macher & Galili, 2008; Takayama et al., 1999). Pieces 
of evidence show that UDP-GalT, located in Golgi and ER, is abundant in insect cell lines 
(Lopez et al., 1998) and uses UDP-GlcNAc as substrates (Hadley et al., 2014, 2019). The 
UDP-GalT transports both UDP-Gal and UDP-GalNAc, two fundamental sugar-
nucleotide donors for α-Gal biosynthesis inside the Golgi apparatus (X. Chen et al., 2002; 
Segawa et al., 2002).  
 
Mutations that inactive the UDP-GalT gene resulted in the abolition of transporter into 
the Golgi lumen, having several effects on N- and O-linked glycans, glycosaminoglycans 
(GAGs), and glycosphingolipids expression (Hadley et al., 2019). Studies performed 
within the mutant MDCK (Madin-Darby Canine Kidney) cell line deficient in UDP-GalT 
present reduction on galactosylation of glycoproteins, glycosphingolipids, and 
proteoglycans (L. Liu et al., 2010).  
 
Since α-Gal synthesis-associated genes have not been identified yet, we targeted the 
UDP-GalT to attempted to disrupt α-Gal production. Gene silencing using the dsRNA 
technique is considered a good approach to disrupt efficiently gene function in distinct 
tissues of adult mosquitoes (Blandin et al., 2002; Boisson et al., 2006) and mosquito cells 
(Levashina et al., 2001). Using specific dsRNA targeting the Anopheles UDP-GalT gene 
we were able to reduce significantly the amount of α-Gal detected, especially when anti-




α-Gal-mAb was employed (Figure 28 and Figure 29) giving strong evidence for the 
association between the transporter and α-Gal expression.  
 
Targeting the UDP-GalT gene resulted in a reduction of α-Gal expression, but it was not 
possible to obtain a total elimination. This could be related to many factors including the 
efficiency of the approach used to silence the gene (i.e. dsRNA) (Boisson et al., 2006). 
Additionally, it has been proposed that UDP-Gal can be imported from the endoplasmic 
reticulum into the Golgi lumen by vesicular transport of nucleotide sugars in a passive 
movement, that could compensate for a decrease in UDP-Gal transporter (Kabuss et al., 
2005), compensating the decreased rate of NST in Golgi lumen, including the UDP-Gal 
(Sosicka et al., 2019).   
 
Once we show that the reduction of UDP-GalT expression reduces α-Gal expression in 
mosquito cell lines we silenced the same gene in adult mosquitoes and evaluated the SG 
invasion by Plasmodium SPZ. A significant decrease in the number of SPZs in the SG 
was observed when the UDP-GalT gene was silenced (Figure 33) indicating that, 
mosquito’s α-Gal epitope is important for Plasmodium SGs invasion but is not important 
for oocyst development. 
 
Surprisingly, when α-Gal expression, detected by the anti-α-Gal mAb, was quantified in 
SPZs from MGs of UDP-GalT silenced mosquitoes a significant reduction was observed 
(Figure 32), reinforcing the idea that a complex interplay between mosquito and parasite 
glycosylation systems might occur with mosquito UDP-GalT playing a role on α-Gal 
synthesis by Plasmodium in this particular life cycle phase. 
 
3. Plasmodium α-Gal origin 
Previous studies (Ramasamy & Field, 2012) and our results demonstrate α-Gal expression 
on Plasmodium (Figure 13, Figure 14, and Figure 15), even so, so far no homologous of 
α-1,3-GalT enzyme gene has been detected in the Plasmodium genome (Takayama et al., 
1999; Boix et al., 2002; Galili, 2013; Yilmaz et al. 2014). This led us to hypothesize that 




α-Gal observed on Plasmodium could be originated in the mosquito. However, our results 
indicate that Plasmodium is capable of synthesizing α-Gal, as in vitro cultures of 
ookinetes, without any mosquito cells can express α-Gal at their surface (Figure 13), and 
when the α-Gal expression was disrupted in the mosquito by silencing the UDP-GalT 
gene, non-major effect on SPZs α-Gal expression was observed (Figure 31). In previous 
studies, α-Gal epitopes have been detected on Plasmodium blood-stage ( Yilmaz et al., 
2014; Ramasamy & Field, 2012) reinforcing the idea that Plasmodium can produce α-
Gal, probably through alternative pathways (Cova et al., 2015). 
 
Enzymes α-1,3-GalT and β-1,4-GalT use UDP-Gal as sugar donors with different sugar 
acceptors (Takayama et al., 1999). UDP-Gal is found in the cell cytosol and is transported 
into RE and Golgi complex by UDP-Gal Transporter (Liu et al., 2013; Sprong et al., 2003). 
The UDP-GalT is directly involved in α-Gal biosynthesis (X. Chen et al., 2002; Segawa 
et al., 2002), and in the absence of a better choice (i.e. α-1,3-GalT enzyme gene), 
analyzing the expression of this NST on Plasmodium SPZs, could give us information 
about α-Gal expression either in Plasmodium (Cova et al., 2015) or Anopheles mosquitoes 
(Aumiller; & Jarvis, 2002).  
 
UDP-GalT has already been described in the ER and Golgi complex of  Plasmodium 
(Bandini et al., 2019; De Macedo et al., 2010; Martin et al., 2005) and seems to have an 
important role in malaria drug resistance (Lim et al., 2016). Using different time points 
(from 8 dpi to 23dpi) P. berghei UDP-GalT gene expression was analyzed using samples 
from MGs and SGs SPZs (Figure 26). From our data, it was not possible to establish a 
correlation between the post-infection time and the gene expression in MGs samples, but 
surprisingly SPZs from SGs show a constant increase in the gene expression. 
 
N-and O-glycosylation occurs on Plasmodium and seems to be important for parasite and 
host interaction (De Macedo et al., 2010) and UDP-GalT is a key factor for the 
Plasmodium O-glycosylation process (Bandini et al., 2019). Therefore, it is very 
interesting to note that SPZs from SGs on 14dpi presented the lowest UDP-GalT gene 
expression matching the lower α-Gal expression detected by flow cytometry (Figure 24). 




When NSTs, such as UDP-Gal/GlcNAc, UDP-GalNac, and UDP-Man were targeted on 
Trypanosoma brucei defective glycosylation in this parasite was observed (Liu et al., 
2013) showing how important the NSTs are for the parasite glycosylation process.  
 
4.  α-Gal and the interaction between SPZs and mosquito  
4.1 SPZs invasion of SGs from mosquitoes silenced for CTL genes 
Glycosylation has an important role in biological recognition (reviewed by Bandini et al., 
2019; De Macedo et al., 2010; Moremen et al., 2012) and assuming α-Gal epitope has a 
crucial role in Plasmodium SPZ invasion of SGs, targeting potential α-Gal receptors on 
mosquito seems to be a plausible approach to understand the role of α-Gal in this process 
and the o C-type lectin-galactose binding (CTLGA) were a natural targeted.  
 
The C-type lectins contain carbohydrate recognition domains (CRDs) and play an 
important role in insect immune response (Xia et al., 2018). In An. gambiae mosquitoes 
a total of 22 members of C-type lectin have been identified (Osta, Christophides, & 
Kafatos, 2004).  The presence of these C type-lectins on SGs of female mosquitoes (Liu 
et al., 2014; Wu et al., 2010), playing an important role in mosquito and parasite 
interaction. Studies using A. aegypti infected with Japanese encephalitis virus (JEV) show 
that the virus envelops (E) protein interacts with the mosquito C-type lectin through an 
N-glycan, which is likely a high-mannose N-glycan (Liu et al., 2017). In another study, 
the authors show that an A. aegypti galactose specific C-type lectin is involved in the 
interaction between the surface envelop (E) Protein of DENV-2 virus facilitating the virus 
infection of mosquito tissues (Liu et al., 2014).  
 
Only one of the three CTLGA targeted was successfully silenced decreasing 
approximately 40% of the SPZ number of SGs and MGs when compared with the control 
(Figure 35). Most studies on C-type lectin of Anopheles infected with Plasmodium are 
focused on the mosquito immune response (Clayton et al., 2014; Osta, Christophides, 
Vlachou, et al., 2004; Xia et al., 2018). In another vector, A. aegypti, the interaction with 
DENV-2 is very affected when CTLGA gene expression is reduced (Y. Liu et al., 2014), 




actually genes that code for proteins containing C-Type domains are found upregulated 
during mosquitoes arbovirus infection (Adelman & Myles, 2018).  
 
Two Anopheles C-type lectins CTL4 (AGAP005335) and CTLMA2 (AGAP005334)) 
have been described as playing an important role in Plasmodium infection. However, the 
way they determine the infection outcome is complex. They are involved in melanization 
responses and can be agonists or antagonists of infection varying with the mosquito 
species and parasite burden (Osta, Christophides, & Kafatos, 2004; Simões et al., 2017) 
and can bind as monomers or heterodimers to different glycans (Bishnoi et al., 2019).  
 
Our results show that the Plasmodium and Anopheles interaction is affected by mosquitos' 
CTLGA gene expression either during oocyte maturation or SGs invasion. α-Gal 
expression increases on SPZs from SGs in mosquitoes injected with dsRNA for the 
CTLGA gene compared with the control (Figure 36). CTLGA bid to galactose 
carbohydrate in a very high-affinity way (Drickamer, 1992) and seem to be important for 
cell-to-cell interactions (Kobayashi et al., 2014; Manning et al., 2017). Even if this is 
strong evidence that Plasmodium α-Gal interacts with mosquito C-type lectin we do not 
have enough evidence to explain how this is occurring. The decreased number of SPZs 
and the amount of α-Gal detected on SG SPZs could be a consequence of less lectin 
available. CTLGA could act as a Plasmodium infection agonist as observed for CTL4 and 
CTLMA2 lectins (Bishnoi et al., 2019). 
 
4.2 SPZs gliding motility target by anti- α-Gal 
Plasmodium ookinetes and SPZs use gliding for movement and host cell invasion 
(Frischknecht et al., 2004). In the process of SGs invasion by Plasmodium, the gliding 
movement is essential (Frischknecht et al., 2004; Vlachou et al., 2006). A trail of SPZ 
component is left during this movement, as observed with CSP (Vanderberg, 2014), and 
is a good indicator that this particular component (detected in the trail) might be involved 
in motility and invasion. Using a Chamber SlindeTM (lab-tek®) and immunofluorescent 
microscopy we attempted to identify if SPZs release α-Gal during gliding. No α-Gal-trail 




was observed, suggesting that α-Gal is not involved in SPZs movement (Figure 38). To 
confirm this observation a live image experiment was performed to determine the effect 
of BS-BI4 Isolectin or anti-α-Gal-mAb on the SPZs movement. In agreement with the 
previous experiments, no significant influence on speed or movement of SPZs was 
observed when α-Gal was blocked by the lectin or the antibody, a slight effect was 
observed on the percentage of moving SPZs when treated with BS-BI4_Isolectin (Figure 








CHAPTER V: CONCLUSION 
 
The α-Gal epitope is present on the surface of Plasmodium on all sporogonic cycle stages 
and mosquito’s midgut and salivary glands. The presence of α-Gal on the SPZs surface 
has already been demonstrated by ( Yilmaz et al., 2014), but our data expand this 
observation to the other sporogonic stages and detect for the very first time this glycan on 
mosquitoes and mosquito hemocyte-like cell lines. 
 
The α-Gal epitope was detected on all sporogonic stages of Plasmodium, including on 
ookinetes, oocysts surface and sporozoites from oocysts and hemolymph but the 
expression of this glycan is higher on the SPZs from SGs, indicated a possible role on 
SPZ maturation and SGs invasion. From our data, and despite the α-1,3-GalT being absent 
from the Plasmodium genome, α-Gal epitopes on Plasmodium is has parasite origin, since 
when mosquitoes α-Gal production is disrupted no significant reduction of α-Gal is 
observed on Plasmodium. This is reinforced when α-Gal epitopes are detected on 
ookinete stages cultured without any mosquito material.  
 
Once no homologous α-1,3-GalT gene was found either in Anopheles or in Plasmodium, 
interrupting other genes involved in α-Gal epitope synthesis, as the UDP-GalT seems to 
be a good strategy. As expected, our results show that mosquito UDP-GalT gene silencing 
reduces α-Gal epitope production in Anopheles mosquitoes, further it can also influence 
Plasmodium α-Gal epitope production. Disturbing the production of α-Gal epitopes from 
mosquitoes by UDP-GalT silencing reduced the number of SPZs reaching SGs, 
suggesting strong crosstalk between oocyst and mosquito as previously suspected, and 
indicating that this mosquito glycan plays a role during the process of SGs invasion.  
 
In a nutshell:  
 
1) The α-Gal epitope has expressed the parasite during the whole sporogonic cycle; 
 




2) The α-Gal epitope production by both, parasite and vector, is mediated by mosquito 
UDP-GalT.; 
 
3) Reduction of mosquito UDP-GalT activity:  
a)  reduces the number of SPZs in SGs but not in MGs (Figure 33);  
b) decreases intensity and % of α-Gal expression in SPZs from MGs (Figure 32) but 
not in SPZs from SGs (Figure 33); 
Suggesting that α-Gal assembly within the oocyst might depend on UDP-Gal from 
the mosquito and the resulting reduction of α-Gal on SPZs from MGs have an 
impact on SGs invasion as seen by the decrease of SPZs in the SGs. 
 
4) Silencing a putative receptor for α-Gal, CTLGA did not affect the % of SPZs from 
MGs expressing α-Gal or on the amount expressed (Figure 37) while an increase of 
both indicators in SPZs from SGs (Figure 36). A reduction in parasite number (Figure 
35) was observed.  
Suggesting that CTLGA might play an agonist of infection. Speculating, we 
suggest that it can mediate SPZs salivary gland entry. Other mechanisms are 
clearly in action, as parasites, although in lower numbers, can be detected in SGs. 
The lower interaction events with the receptor (CTLGA) could explain the higher 
α-Gal expression observed on SPZs in the salivary glands and once inside this 
organ α-Gal keeps being expressed (Figure 20). 
 
5) SPZ gliding trail does not have α-Gal. 
Indicating that SG invasion mediated by α-Gal does not depend on gliding motility, 
reinforcing the idea that α-Gal epitope is acting through a receptor/ligand 
associated mechanism.  
 
  






Discovery and understanding of the mosquito α-Gal pathway could be interesting special 
for a possible blocking transmission strategy based on this glycan. 
 
The α-Gal epitope production on Plasmodium remains unsolved, and more studies based 
on nucleotide sugar transporter (NST) genes could be a way to highlight this question. 
UDP-GalT is related to α-Gal epitope in mosquitoes and could have the same effect on 
Plasmodium. Because the UDP-GalT gene silence produces a lethal mutation on the 
parasite, a conditional gene silencing strategy could be used to highlight the role of this 
NST on α-Gal epitope on Plasmodium. 
 
As data indicates that α-Gal role in salivary gland invasion is mediated by a 
receptor/ligand-associated mechanism, this should be further investigated using mutants’ 
mosquitoes for specifics genes like CTLGA. 
 
Characterizing the interplay of α-Gal and oocyst development, the sporozoites within 
and egress also would broaden the role of α-Gal on sporogonic development other than 
SG invasions. 
 
Clarify if Plasmodium α-Gal can bind to mosquito’s lectin, special those found in the 
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Annex I: Detection and quantification of Plasmodium berghei UDP-Gal-Transporter 
gene expression in SPZs from MGs and SGs – Plasmodium 18S gene and UDP-GalT 




Annex II: Anopheles stephensi UDP-Gal transporter gene silencing: PCR and 
dsRNA gel 
A – PCR molecular weight marker; B and C – Electrophorese gel of PCR product from β2M gene; D and 
E - Electrophorese gel of PCR product from mosquito´s UDP-Gal transporter gene; F and G – Mosquito´s 
UDP-Gal transporter gene dsRNA; H and I - β2M gene dsRNA. 
Efficiency = 96.78% Plasmodium 18S gene
Efficiency =  99.33% Plasmodium UDP-GalT gene
A-H Agarose gel (1.5%) form PCR product of Plasmodium
18SrRNA gene (B-C) and Plasmodium UDP-GalT (E-F); 






Annex III: The role of α-gal in sporozoite invasion of salivary glands; Anopheles 
stephensi lectin binding-Gal gene silencing: PCR AND dsRNA Gel 
Mosquito´s lectin binding-Gal gene dsRNA: A and H - PCR molecular weight marker; B and C – 
Electrophorese gel of PCR product from gene ASTE0001078; D and E - Electrophorese gel of PCR 
product from gene ASTE0005491; Electrophorese gel of PCR product from gene ASTE0005494;D and E 
-  dsRNA of ASTE005491 gene  
 
Annex VI: Mosquitoes cells cultivation: phase-contrast microscopy imagen of three 












Annex V α-Gal detection in different Anopheles mosquito cell lines.  
Phase-contrast microscopy image; Cells stained with lectin IBS-B4 conjugated with Alexa647 (red). 
Nuclei were stained with DAPI (blue); Bar = 50µm. 
 
Phase-contrast microscopy image; Cells stained with anti-α-Gal-mAb and secondary mAb conjugated 
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